Applications of Rapid Cardiac Micro-CT by Detombe, Sarah A
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
4-18-2012 12:00 AM 
Applications of Rapid Cardiac Micro-CT 
Sarah A. Detombe 
The University of Western Ontario 
Supervisor 
Dr. Maria Drangova 
The University of Western Ontario 
Graduate Program in Medical Biophysics 
A thesis submitted in partial fulfillment of the requirements for the degree in Doctor of 
Philosophy 
© Sarah A. Detombe 2012 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Biophysics Commons 
Recommended Citation 
Detombe, Sarah A., "Applications of Rapid Cardiac Micro-CT" (2012). Electronic Thesis and Dissertation 
Repository. 497. 
https://ir.lib.uwo.ca/etd/497 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
 
 
 
APPLICATIONS OF RAPID CARDIAC MICRO-CT 
 
 
 
(Thesis Format: Integrated-Article) 
 
by 
 
Sarah A. Detombe 
 
 
Department of 
Medical Biophysics 
Schulich School of Medicine and Dentistry 
 
 
 
Submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
 
 
School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
London, Ontario 
 
 
April 2012 
 
 
 
© Sarah A. Detombe 2012 
 ii 
THE UNIVERSITY OF WESTERN ONTARIO 
SCHOOL OF GRADUATE AND POSTDOCTORAL STUDIES 
 
Certificate of Examination 
 
 
Chief Advisor 
 
_________________________________ 
Maria Drangova, Ph.D. 
 
 
Advisory Committee 
 
_________________________________ 
David W. Holdsworth, Ph.D. 
 
_________________________________ 
Qingping Feng, M.D., Ph.D. 
 
Examining Board 
 
_________________________________ 
James Lacefield, Ph.D. 
 
_________________________________ 
Ting-Yim Lee, Ph.D. 
 
_________________________________ 
Morris Karmazyn, Ph.D. 
 
_________________________________ 
John Sled, Ph.D. 
 
 
 
 
 
 
The thesis by 
 
Sarah A. Detombe 
 
entitled: 
 
Applications of Rapid Cardiac Micro-CT 
 
is accepted in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy 
 
 
 
 
Date  __________________   _________________________________ 
      Chair of Examining Board 
 
 iii 
 
Abstract 
Mouse models are an important tool in cardiovascular disease research, and a 
non-invasive imaging method is an advantageous way of monitoring disease progression.  
Cardiac micro-CT is rapid imaging technique capable of quantifying changes in cardiac 
structure and function in mice.  The goal of this thesis was to demonstrate the utility of 
this technique in monitoring disease progression in a longitudinal study, as well as its 
capability for evaluating other methods of measuring cardiac function in mice. 
In a longitudinal study, a mouse model of myocardial infarction was scanned 
weekly for four weeks; left ventricular volume and ejection fraction were measured from 
the images.  Cardiac micro-CT was capable of tracking small changes in cardiac structure 
and function, with the MI mice demonstrating a significant increase in volume and a 
significant decrease in ejection fraction.  Both inter- and intra-variability was low, 
indicating the results were highly reproducible. 
Contrast agents are essential to evaluating the heart in micro-CT images.  A new 
blood-pool agent was evaluated to determine its suitability for use in cardiac micro-CT 
studies.  The agent produced excellent enhancement for the first 30 minutes post-
injection, and had a unique characteristic of enhancing the myocardium, which may 
prove useful in studies evaluating wall motion. 
The effect of x-ray dose delivered during a longitudinal micro-CT study was also 
evaluated.  C57BL/6 mice were scanned weekly for six weeks; the total entrance dose 
delivered over the study was 5.04 Gy.  No significant changes to the heart or lungs were 
detectable on the micro-CT images at six weeks, and the histology performed on 
myocardial and pulmonary tissue showed no indication of early inflammation at a cellular 
level.  Micro-CT can therefore be used in longitudinal studies without concern of adverse 
effects. 
Cardiac micro-CT was used to evaluate conductance catheters, and found that the 
catheter volumes were drastically underestimated compared to the micro-CT volumes.  It 
was also determined that catheterization has the potential for causing cardiac 
enlargement; 40% of the mice demonstrated enlarged hearts following the catheterization 
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procedure.  Overall, cardiac-gated micro-CT is a rapid and reproducible imaging 
technique, and is proving to be valuable tool in cardiovascular disease research. 
 
Key Words: cardiac micro-CT, micro-computed tomography, retrospective gating, 
contrast agent, conductance catheter, x-ray dose, mouse model, left ventricle, ejection 
fraction, cardiovascular disease 
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1 Introduction 
1.1 Overview 
Cardiovascular diseases (CVD) are the leading cause of mortality worldwide, 
responsible for over 17.3 million deaths per year.1  In Canada, 29% of all deaths annually 
are attributed to CVD,2 and it is estimated to cost the Canadian economy $20.9 billion 
every year.3  But on a positive note, the country has also seen a steady decline in deaths 
related to CVD over the past forty years, which can be partly attributed to the research 
investigating treatment strategies and prevention.  An abundance of this research is 
performed in mouse models, a necessary step in translating basic science research to 
implementation in human patients; given the importance of preclinical investigations, the 
development of techniques specifically designed to assess cardiac function in small 
animals is an essential area of research.  Cardiac micro-computed tomography (micro-
CT) is one such technique, which offers a rapid, non-invasive imaging method to monitor 
changes in cardiac structure and function over time, providing quantitative information 
on both ventricular volume and function. 
The goal of this thesis is to demonstrate the role of micro-CT in cardiac studies 
involving mouse models.  A method for retrospectively gating cardiac micro-CT scans 
had been recently developed (fully detailed in Appendix A), and the next step was to 
assess the ability of this technique to measure quantitative changes in both ventricular 
volume and cardiac function over time.  Several key aspects of micro-CT imaging were 
also investigated: the use of a contrast agent is important for differentiating the blood 
pool from the myocardium, and a new agent had shown some unique properties that were 
investigated for their applicability to cardiac studies.  Additionally, a frequent concern 
associated with micro-CT imaging is the x-ray dose delivered to the animal, which 
becomes more relevant in longitudinal studies where an animal is imaged multiple times.  
Therefore, the effects of dose on cardiac and pulmonary tissue, delivered during a 
longitudinal study, were evaluated.  Finally, cardiac gated micro-CT was used to 
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determine if another frequently used measurement technique, conductance 
catheterization, had any detrimental effect on the mouse heart. 
In order to provide some context for the subsequent chapters, this chapter first 
discusses the advantages of using mouse models, as well as some of the cardiovascular 
diseases that can be modeled.  Methods used to evaluate the cardiovascular system in 
mice are briefly outlined, as well as the advantages of employing imaging techniques.  
Options for cardiovascular imaging are presented, followed by a more detailed discussion 
of computed tomography in general, and of cardiac micro-CT more specifically.  Some of 
the key elements associated with micro-CT, including use of a contrast agent and the 
radiation dose delivered to the animal, are explored, and finally, some potential 
applications of cardiac micro-CT are presented, followed by a more detailed outline of 
the thesis chapters. 
 
1.2 Preclinical Cardiovascular Research 
Clinical investigation of cardiovascular diseases is an important approach for 
trying to understand etiology and the impact of therapies, but animal models are essential 
tools for determining the mechanism of pathogenesis, as well as investigating 
interventions.  With animal models it is possible to investigate a risk factor as a single 
independent variable, given the well-known genetic characteristics, as well as the absence 
of any abnormalities.  New diagnostics, treatments, and preventative procedures are also 
best performed in animals, given ethical and practical considerations. 
Large animal models are often used as a final step before beginning clinical 
investigations.4  Dogs, sheep, and pigs are common species, and the decision of which 
animal to use is based on the disease or disorder being modeled, as each species best 
reflects different aspects of human cardiac physiology.5  Small animal models have 
greater differences in physiology compared to humans, but much of the insight into the 
molecular and cellular basis of cardiovascular biology is a result of using these smaller 
species, particularly mice.6 
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1.2.1 Advantages of Mouse Models 
One of the major advantages of using the mouse as a small animal model of 
cardiovascular disease is the availability of well-defined genetics.  Highly standardized 
mouse strains have been created, whose genetic characteristics are precisely known,7 and 
the use of these inbred strains has offered the ability to investigate disease at the genomic 
level; the genetic background of a mouse can be manipulated very precisely and with 
relative ease, which can then be correlated to the phenotype of a living animal.  Use of 
transgenic mouse models enables specific characteristics of cardiovascular disease to be 
investigated,6 and it also offers the opportunity to define new therapeutic strategies that 
may one day be of use to the human population.  In addition, use of the mouse to model 
diseases is also popular due to the economic and practical benefits of working with small 
animals. 
The size of the mouse, and consequently the heart, is the main challenge of 
working with the species; the small size and rapid heart rate can act as an impediment to 
investigations.8  However, advances in technology have led to the availability of 
increasingly diminutive tools and more sophisticated measurement techniques, making it 
easier for researchers to benefit from the advantages of using mouse models.  
 
1.2.2 Cardiovascular Disease Models 
Many cardiovascular diseases can be modeled in mice, through genetic 
manipulation, surgical interventions, pharmacological agents, or through changes in 
external factors such as diet modifications.  For example, atherosclerosis is modeled in 
mice by the generation of plaques caused by hyperlipidemia.  Hyperlipidemia can be 
induced by using a genetically modified mouse model that lacks ApoE, or a model 
deficient in LDL receptors,9, 10 both of which result in increased cholesterol levels in the 
bloodstream.  Hyperlipidemia can also be induced by dietary modifications, changing the 
mouse’s normal chow to one high in saturated fat and cholesterol;9 a combination of the 
two methods is also used.11 
Pharmacological agents can also be used to induce a cardiovascular disease state.  
Angiotensin II is a peptide hormone that is responsible for constricting blood vessels and 
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increasing blood pressure, but it has also been discovered that chronic subcutaneous 
infusion leads to the development of abdominal aortic aneurysms through direct 
inflammatory effects.12 
A mouse model of myocardial infarction, on the other hand, is created through 
surgical intervention.13  The thorax of the mouse is opened and, commonly, the left 
anterior descending coronary artery is ligated to create an infarct in the apex region of the 
left ventricle.  This model could either represent a chronic infarction, where the ligation is 
left in place,14, 15 or a reperfusion model, where the ligation is removed after a certain 
period of time.16, 17 
 
1.2.3 Methods of Evaluation 
There are a number of techniques used to evaluate and quantify the disease 
process in mice.  They are often terminal in nature, requiring that the heart be removed 
for evaluation.  For example, histological evaluation of the aortic root,18 or cross-sections 
of fixed aortas, is used to quantify atherosclerotic lesions, as well providing the 
opportunity for morphological analysis.   Evaluation of the weight and diameter of the 
heart can also provide useful information in cases of cardiac hypertrophy.  Myocardial 
infarctions are often quantified through histology;19 blood markers (i.e. cardiac proteins) 
can also provide useful data.20 
Catheterization is also often used in cardiac analysis.  Electrophysiological 
catheters can be inserted into the right ventricle (RV) and changes to the conduction 
system of the heart investigated.21, 22  Conductance catheters are a frequently-used 
method of monitoring cardiac function.  This is accomplished by inserting a pressure-
conductance catheter, measuring 1.4F in diameter, into the left ventricle (LV).  The 
catheter contains a pressure sensor, which measures the pressure of the LV, and four 
electrodes, which create an electric field and measure the conductance of the blood within 
the LV.  Conductance measurements are converted to volume measurements using the 
equation V = "L2 (G - Gp)/! where " is the resistivity constant, L is the length between 
the electrodes, ! is Baan’s constant, G is the total conductance measured, and Gp is the 
parallel conductance of the surrounding tissue.  When combined with the pressure 
measurements, real-time pressure-volume loops are created that give information about 
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heart function and myocardial health.23, 24  Both types catheters are often inserted into the 
heart retrograde through the aortic valves, and although in theory they can be removed 
without requiring the animal be sacrificed, that is not usually the case. 
As technology continues to improve, non-invasive methods are becoming 
increasingly available.  Imaging techniques can be used to quantify atherosclerotic 
plaques25, 26 and myocardial infarcts,13, 27 and measure the size and mass of the heart,28, 29 
without sacrificing the animal.  Echocardiography is especially useful for non-invasive 
hemodynamic measurements.28  Several imaging modalities used in CVD research are 
detailed in the next section. 
 
1.3 In vivo Micro Imaging 
One of the key advantages of in vivo imaging of mouse models is the non-
invasive nature of the technology.  The ability to evaluate the heart in vivo may provide 
information about morphology that would be lost by the removal of the organ.  Individual 
animals can also be followed throughout the study, rather than sacrificing a group of mice 
at each time point; this may decrease the number of animals required for a study to reach 
statistical significance, with the added advantage of tracking disease progression or 
treatment process in the same animal. 
 
1.3.1 Echocardiography 
Echocardiography is a rapid and portable imaging technique, making it easy to 
integrate into active physiology research labs.  Its value in investigations employing 
mouse models has increased since the availability of high-frequency small-animal 
ultrasound devices, which have a resolution range of approximately 65 #m – 200 #m, 
making it easier to evaluate the small anatomy of the mouse.30  Even more significant to 
the field of cardiovascular imaging has been the introduction of linear array transducers, 
which, along with a high resolution, have an increased frame rate that enables the ability 
to evaluate individual phases of the cardiac cycle with sufficient temporal resolution.30 
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Although 3D echocardiography has been demonstrated,31 left ventricular volume 
is typically measured using M-mode or 2D images.  This necessitates the translation of 
2D measurements to 3D volumes, which requires geometric approximations; although 
these approximations may produce reasonably accurate volumes of a healthy, regular-
shaped heart, if the organ is misshapen or distorted, as it would be in models of 
myocardial infarction, for example, it would be more difficult to obtain accurate 
measurements.  Additionally, since measurements are taken from only one longitudinal 
plane, foreshortening may occur, where the ultrasound beam is not passing directly 
through the centre of the chamber, creating artificially smaller chamber dimensions, and 
resulting in a smaller LV volume. 
One of the key advantages of echocardiography is the ability to measure 
hemodynamic function non-invasively;28 for example, flow velocity in arteries or through 
cardiac valves can be quantified using Doppler imaging.  This imaging technique may 
also be used to evaluate myocardial strain, through the use of tissue Doppler imaging. 
 
1.3.2 MRI 
Magnetic resonance imaging (MR/MRI) enables the acquisition of high-resolution 
images, with high soft tissue contrast.  MR images are typically anisotropic, with an in-
plane resolution between 50 #m and 120 #m, and slice thicknesses of approximately 1 
mm.  Although 3D cine MRI with isotropic resolution has been demonstrated,32 time 
constraints may be a limiting factor, as one scan with sufficient SNR typically takes more 
than one hour to acquire. 
Cine MRI can be used to evaluate both cardiac structure and, with the use of 
gating techniques, cardiac function.33  MRI has the advantage of not requiring a contrast 
agent to evaluate the heart.  Bright blood imaging methods are typically used, but black 
blood cine imaging can also be performed,34 which provides more accurate measurements 
of LV mass and volume; the acquisition time, however, more than doubles.  The 
definitive myocardial boundaries enable the measurement of wall mass, which can be 
used to track cardiac hypertrophy in mouse models displaying cardiomyopathy.34, 35  The 
high resolution of soft tissue also enables wall motion measurements to be acquired, for 
example with the use of tagged cine MRI.36 
7 
 
MRI typically has long exam times, made longer still with the use of gating to 
capture individual phases of the cardiac cycle.  This has implications on the health of the 
animals being scanned – the longer they are under anesthetic, the greater the risk of 
developing complications; the risk is more significant with mouse models that are likely 
already in compromised health. 
 
1.3.3 Nuclear Medicine Imaging 
Molecular imaging is a growing field that includes single photon emission 
computed tomography (SPECT) and positron emission tomography (PET), both of which 
are imaging modalities that use radionuclides as tracers.  One of the main advantages of 
this type of imaging is the ability to study dynamic biologic processes within in vivo 
mouse models.  For example, areas of myocardial ischemia can be detected by changes in 
perfusion, measured via SPECT imaging after injection of 99mTc-sestamibi.37 
Micro-SPECT imaging probes are labeled with gamma-emitting radionuclides 
that are detected using SPECT cameras with lead collimators.  Micro-PET probes are 
labeled with positron-emitting radionuclides, which produce gamma rays through 
annihilation events.  Both imaging techniques are highly sensitive to trace amount of 
radioactivity, enabling small amounts of an individual probe to be used.  However, both 
technique have a relatively low resolution (micro-SPECT has a resolution of 0.5 mm – 
2mm; micro-PET has a resolution of 1 mm – 2 mm), and require a generator/cyclotron to 
produce the necessary radionuclides.38  There is also a lack of anatomic information 
available in SPECT and PET images; this, however, has been improved by using 
combined SPECT/CT and PET/CT images, where the CT provides the necessary 
anatomical boundaries (for example, the myocardial border) to properly interpret the 
SPECT/PET information.38 
 
1.3.4 Micro-CT 
Micro-CT is a rapid imaging method with a high isotropic resolution of 150 #m 
or better.39  Micro-CT is faster and more economical than MRI, and has a higher SNR 
than echocardiography.  However, the inherent low soft tissue contrast of micro-CT 
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requires the use of a contrast agent in cardiac studies,40-42 and it also prevents any 
evaluation of myocardial strain or function.  Also, as micro-CT uses x-rays, another 
concern is the effect of the radiation dose on the animal being scanned, which places an 
upper limit on image quality in an in vivo application.  A more detailed description of 
cardiac micro-CT follows in Section 1.5. 
 
1.4 Overview of Computed Tomography 
Computed tomography (CT) was first introduced by Sir Godfrey Hounsfield in 
the early 1970’s as an imaging technique that uses a series of x-ray projection images to 
generate cross-sectional images, or slices, of an object.43  The images essentially 
represent a map of the linear attenuation coefficients of the object scanned, expressed in a 
matrix of volume elements (voxels).  The intensity of each voxel is proportional to the 
attenuation coefficient and is expressed in Hounsfield units, calculated as:  
 
( ) ,1000# HUCT
water
watertissue !
"
=
µ
µµ  
(1.1) 
where #tissue is the mean attenuation coefficient of the tissue within that voxel.  X-
ray attenuation is primarily a function of x-ray energy and the density and composition of 
the material being scanned. 
The fundamental components of a CT scanner include an x-ray source and a 
detector, which rotate about the object being scanned.  Collimators are used to help 
reduce the dose delivered to the patient, as well as to prevent scattered photons from 
hitting the detector; filters are used remove the low-energy x-rays from an emitted beam 
before they reach the object, in an effort to reduce beam hardening.  The tube’s voltage 
and current values are chosen based on the composition and size of the object being 
scanned. The acquired projection data are typically reconstructed using filtered back-
projection,44 which has traditionally been computationally faster than Fourier transform45 
and algebraic reconstruction techniques,46 although algebraic reconstruction techniques 
are gaining popularity. 
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There have been a number of advancements in scanner geometries over the past 
forty years.47  The earliest systems used a translate/rotate method, during which the 
pencil beam x-ray source and detector moved laterally, then rotated around the object and 
repeated the process; this system required approximately 4.5 minutes to image a single 
slice.  Second generation scanners used a fan-beam x-ray source and an array of 
detectors, thereby improving the speed and efficiency of data collection during the 
translation process.  With this improvement, imaging times were reduced to 2.5 minutes 
per slice.  Third generation scanners employed larger detector arrays, and wider fan-beam 
angles, preventing the need for translation and relying solely on source/detector rotation 
around the object; scan time was further reduced to 18 seconds.  Fourth generation 
scanners replaced the moving detector array with a fixed detector ring; however, because 
these scanners tend to be more expensive and suffer from higher levels of Compton 
scatter artifacts, most of the commercial CT scanners available today are third generation.  
The improvement in scan times enabled the CT scanner to become widely used in whole-
body imaging, and was capable of imaging fairly static cardiac structures such as the 
pericardium, the contracting heart was not well visualized.  A further problem existed in 
the form of scanner cabling restricting the tube movement; this was solved in the early 
1990’s with the introduction of slip-ring technology,48 enabling continuous acquisition of 
data over multiple rotations.  Combined with increasingly fast scanners, decreases in 
detector element size, and the introduction of multislice detector CT scanners, imaging of 
dynamic processes such as the beating heart are now possible, when combined with 
gating techniques.49 
The spatial resolution of clinical scanners (i.e. 1 mm3 voxel elements) prevented 
their use in investigations using small animals, but technical advances in computing 
speed and detector technology made it possible to obtain images of small-specimens and 
-animals with a resolution measured in micrometers.50  
 
1.5 Micro-computed tomography 
Micro-CT was first developed in the early 1980’s51, 52 for use in applications with 
very fine structures that required a high resolution to visualize.  However, in order to 
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provide CT image signal-to-noise ratio (SNR) comparable to clinical CT scanners, the x-
ray exposure of the animal or specimen needed to be increased by an amount proportional 
to at least the inverse of the voxel volume.53  X-ray tubes with a larger focal spot can 
achieve higher fluence rates and therefore an increase in exposure, however this would 
also introduce blurring.  Therefore the only way to increase dose is by using longer scan 
times.  Specimen scanners typically use a micro-focus x-ray tube and variable geometric 
magnification; as x-ray exposure is not an issue with tissue samples, projection data may 
be acquired over a few hours, resulting in high-resolution images with isotropic voxels 
ranging from 15-50 #m over a field of view (FOV) of 15-50 mm.50, 54  In in vivo imaging, 
a compromise between voxel size and shorter scan times is required, both to limit the 
dose delivered to the live animal, as well as to minimize the length of time the animal is 
under anesthetic.  Another difference between specimen and in vivo scanners is that the 
specimen is rotated while the x-ray tube/detector assembly remains stationary, whereas 
with commercial in vivo scanners, the x-ray tube/detector assembly is rotated around a 
stationary animal.50 
 
1.5.1 In vivo micro-CT 
As mentioned in the previous section, in vivo imaging necessitates a decrease in 
resolution in order to limit the x-ray dose delivered to the animal.  The decrease in 
resolution requirements enables the use of lower geometric magnifications and larger x-
ray tube focal spot size, facilitating higher tube current and shorter acquisition times, 
typically 5-10 minutes.50  The resolution of these scanners ranges from 25-100 #m, with 
a FOV of 45-55 mm. 
Traditional micro-CT scanners use a step-and-shoot mode, where the gantry 
moves in a stepwise motion around the animal, and projection data are acquired at each 
position.  The development of a continuous rotation mode, where data are collected 
constantly during a continuous gantry rotation, has decreased acquisition times; with the 
implementation of slip ring technology, commercial scanners such as the GE Locus Ultra 
are capable of rapid multiple continuous rotations, enabling capture of dynamic processes 
in a living animal, such as in cardiac and lung imaging.42, 55 
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In addition to the faster acquisition times, cardiac and lung imaging also require a 
gating method to “freeze” the motion of the organ, necessary for both structural and 
functional evaluation.  A physiological monitoring and triggering system is required, 
such as the BioVet system available from m2m Imaging, to monitor and record the ECG 
and/or respiratory signal of the animal, and to send triggers to the scanner at the 
appropriate time point in the physiological waveforms.  These triggers act as a signal for 
x-ray activation during prospective gating, and are used to identify the appropriate 
projection data when reconstructing images during retrospective gating.  Further 
information regarding these gating protocols is detailed in section 1.5.2. 
Other considerations when imaging live animals is the method of anesthesia used, 
as well as the maintenance of physiological homeostasis while anesthetized.  An 
anesthetic is required to keep the animal motionless during the scans, and to minimize 
stress.  Typical anesthetics used include inhalational anesthetics, such as isoflurane,56 and 
injectable anesthetics such as a ketamine/xylazine combination.57  The most appropriate 
anesthetic depends on the type of study; for example, during cardiac studies isoflurane is 
the best choice, as it has minimal effects on heart rate and cardiac function, and will 
therefore not dramatically interfere with interpretation of the results.56  Body temperature 
maintenance is also an important factor during in vivo imaging, as an animal cannot 
properly maintain its own temperature while anesthetized.  When scanning mice, the 
temperature should remain between 36-37°C to sustain proper physiologic function.  This 
is especially important during cardiac imaging, where body temperature has a significant 
impact on heart rate, and ultimately cardiac function.58  The recent introduction of an 
animal management system,59 capable of maintaining the animal’s body temperature and 
anesthesia level within an enclosed tube, while also monitoring ECG and respiratory 
signals, offers a solution for simplifying the physiological monitoring process during 
micro-CT scans. 
Micro-CT images are based on linear attenuation coefficients, so a contrast agent 
is required when interested in imaging soft tissues.40, 42  For example, during cardiac 
scans, a contrast agent is required to differentiate the blood pool in the heart chamber 
from the myocardium, which is necessary when measuring chamber volumes, or 
evaluating structural changes.  One objective of this thesis has been to evaluate a new 
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blood pool contrast agent and its applicability for use in cardiac studies.  This is further 
discussed below. 
 
1.5.2 Cardiac-gated micro-CT 
In order to evaluate cardiac structure and function, selected phases of the cardiac 
cycle need to be reconstructed.  The challenge of imaging the mouse heart is its small 
size and rapid heart rate, but the development of fast, high-resolution micro-CT scanners 
has helped to address these challenges.  A gating technique is also required to “freeze” 
the motion of the heart; either prospective or retrospective gating can be used.  Both 
gating techniques can also be used to image the lungs: the high contrast between 
pulmonary tissue and the rest of the body makes micro-CT images particularly 
appropriate for evaluating lung function, but a gating method is required to generate 
images in both inspiration and expiration phases.55, 60 
Prospective cardiac gating during a micro-CT scan was first described by Badea 
et al.40, 61  During prospective gating, projection data are only acquired during a selected 
phase of the cardiac cycle, e.g. diastole, with a temporal resolution (i.e. window size) of 
10-15 ms.  In other words, the ECG of the mouse is monitored continuously, and the x-
rays are only triggered when a specific phase is reached.40  The main advantage 
associated with prospective gating is the lower dose delivered to the mouse compared to 
retrospective gating.  The main disadvantage of using prospective gating is length of time 
required: it can take up to 15 minutes to acquire data for only one cardiac phase, making 
it a challenge to carry out high throughput experiments, although recently Guo et al. has 
introduced a fast prospective gating technique that acquires a scan in less than 5 
minutes.62  Additionally, it may be challenging to maintain a consistent heart rate during 
the longer scan, depending on experimental setup; a change in heart rate may alter the 
placement of the desired cardiac phase within the ECG, leading to the x-rays being 
triggered at the incorrect phase. 
Retrospective gating is carried out by continuous acquisition of projection data for 
the duration of the scan.  ECG is monitored and recorded during the scan; following data 
collection, projections occurring at the selected phase of the cardiac cycle are then used 
to reconstruct an image. This enables reconstruction of multiple images of the heart 
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spanning the entire cardiac cycle from one scan.  Retrospective cardiac gating in micro-
CT scans was first described by Drangova et al.;42 using a scanner with a slip-ring gantry, 
projection data were continuously acquired over 10 rotations in a 50-second scan time 
(this scanning and reconstruction technique is fully described in Appendix A).  This 
technique, employed in the study described in Chapter 2, uses a 12 ms fixed window size, 
enabling between nine to twelve images to be reconstructed  throughout the cardiac cycle.  
Retrospective gating is also possible with a step-and-shoot scanner, but the acquisition 
times and doses are much larger.63  The advantage of the retrospective gating technique is 
the rapid scan times and large amount of data acquired in that short time, making it ideal 
for high throughput studies.  One drawback associated with retrospective gating is the 
inevitable irregular angular distribution of the collected projections, which can lead to 
streaking in the reconstructed image; however, reconstruction algorithms have been 
proposed that minimize streaking in the final image.63, 64  One such method, described by 
Armitage et al.,64 uses a least-error sorting technique, where the projections closest to the 
phase of interest in the cardiac cycle are used to fill the view angles.  Approximately 80% 
of the angles can be filled at a fixed window size (i.e. 12 ms), the window is then 
incrementally expanded to fill in the missing views with projections acquired at a slightly 
different phase.  Using the scanning protocol outlined in Appendix A, this results in an 
effective window size of 27 ms.  In Chapters 4 and 5, a variation of the least-error 
technique is used – the images are reconstructed with only the first 80% of view angles 
filled, resulting in a window size close to the 12 ms described in Appendix A, but without 
the streaking artifacts. 
Another potential drawback associated with retrospective gating is the dose; the 
x-rays are on continuously during the scan, leading to a higher delivered dose than during 
prospective gating.  One of the objectives of this work has been to determine the effects 
of x-ray dose during a longitudinal retrospectively gated study on the mouse, and will be 
discussed further below. 
 
1.5.3 Contrast agents 
As was mentioned previously, a contrast agent of radio-opaque material is 
required to enable soft tissue differentiation in a micro-CT image.  Specifically, 
14 
 
evaluating cardiovascular function requires a contrast agent to differentiate between the 
blood in the heart chambers and the myocardium. 
Clinical contrast agents in use, such as iohexol, a nonionic iodinated contrast 
agent, provide excellent contrast between blood and tissue, but are quickly cleared via 
glomerular filtration; this is useful for perfusion studies, but scans measuring cardiac 
function in small animal models require longer scan times with consistent contrast, and 
an optimal protocol using iohexol can be challenging to develop.  A contrast agent was 
therefore required that remained within the blood-pool for an extended period of time.  
Fenestra VC, an iodinated triglyceride (ITG) emulsion containing polyethylene glycol 
(PEG) molecules, was the first to be developed.65  The PEG molecules prevent rapid 
uptake of the ITG by the liver, providing contrast in the blood for over four hours.66  
Other blood-pool agents have since been developed.  For example, Exitron nano 12000 is 
an alkaline earth-based nanoparticulate contrast agent with a delayed uptake by the 
reticuloendothelial system, resulting in sufficient vascular contrast for over two hours.67  
eXIA 160 is another example; it is described as an aqueous colloidal polydispersed 
contrast agent with a delayed diffusion from the vasculature.  But although the liver- and 
spleen-enhancing properties of this contrast agent have been investigated,68 there has not 
yet been an evaluation of its suitability for use in cardiac studies. 
The blood volume of a 25 g mouse is 1.5 – 2 mL, and so contrast agents with a 
higher iodine concentration are more beneficial, as they require a lower injected volume 
to achieve sufficient enhancement and are less likely to disrupt the hemodynamics of the 
mouse.  Fenestra VC has the lowest iodine concentration: at 50 mg/mL, a recommended 
dose is 500 #l for a 25 g mouse, a significant fraction of the animal’s blood volume.40  By 
comparison, in order to achieve the same enhancement, Exitron nano 12000, with an 
equivalent iodine concentration of 300 mg/mL,67 would require an injected volume of 83 
#l, and eXIA 160, with a iodine concentration of 160 mg/mL, would require an injected 
volume of 156 #l. 
 
1.5.4 Radiation Dose 
One of the main perceived drawbacks of micro-CT is a concern over the x-ray 
dose delivered during the scans.  A typical ungated micro-CT scan delivers a dose of 10 
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cGy,69 which, although much smaller than the LD50 of the mouse,70 is larger than the dose 
delivered during a clinical cardiac CT (2-5 cGy).71  This is particularly relevant in 
longitudinal studies, where more than one scan is performed per animal.  Additionally, 
studies requiring cardiac or pulmonary gating deliver a larger dose.42 
In cardiac studies, the main tissue of interest is the myocardium; x-ray damage 
can result in necrotic and fibrotic areas developing in the tissue, contributing to radiation-
induced cardiac hypertrophy.72  However, cardiac tissue is not particularly radiosensitive, 
and therefore not the best choice for determining dose effects in mice.  Pulmonary tissue, 
on the other hand, is one of the most radiosensitive in the body; the lungs will therefore 
be the first to display the effects of x-ray dose, making it the ideal organ to use for 
evaluation.  X-ray damage in the lungs generally presents in two phases, an early 
inflammatory phase, often called radiation pneumonitis, and a later chronic fibrosis 
phase.73  For the purposes of most micro-CT studies the early inflammatory phase is the 
most relevant; it results in an increase in inflammatory cells building up in the alveoli and 
pulmonary ducts of the lungs, resulting in a decrease in lung volume, and an increase in 
lung density. 
There have been a number of studies looking at the effect of dose on pulmonary 
tissue in mice;74, 75 however, they have focused mainly on investigating radiotherapy 
doses of 10-20 Gy delivered in a single session at the beginning of the study.  
Additionally, evaluation of dose effects typically does not begin for 8-12 weeks 
following delivery.  This creates some difficulties in trying to apply the results of these 
studies to a typical micro-CT study, where the doses are smaller, often by a factor of 100, 
delivered multiple times over a period of weeks, in a study less than 8 weeks in length.  
The effect of dose during a longitudinal micro-CT study has not yet been investigated. 
 
1.5.5 Potential Applications of Cardiac micro-CT 
Cardiac micro-CT offers numerous advantages for investigating cardiovascular 
diseases.  For example, the fast acquisition time facilitates high throughput studies; high-
resolution isotropic voxels enable direct volume measurements without the need for 
estimations or approximations, increasing the accuracy of the measurements; and from 
these scans both qualitative, structural information and quantitative data can be acquired.  
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And ultimately, the non-invasive nature makes longitudinal evaluations possible.  The 
benefits of micro-CT suggest a number of potential applications: the high throughput 
ability would be especially beneficial when identifying phenotypes of various mouse 
strains; technique can also be used to evaluate longitudinally the progression of diseases, 
or the evaluation of various therapies, that affect the structure or function of the heart.  
Additionally, cardiac micro-CT can also be used to evaluate other methods of measuring 
cardiac function, to determine if there are ways to improve the commonly used 
methodologies. 
 
1.6 Hypothesis 
I hypothesize that cardiac-gated micro-CT can be used to accurately and 
reproducibly evaluate, both quantitatively and qualitatively, cardiac structure and 
function in mouse models.  I further hypothesize that this technique can be safely 
employed in longitudinal studies, to monitor disease progression, and also be used to 
evaluate other methods of measuring cardiac function in mice.  In order to test these 
hypotheses, several objectives were set: 
1. To evaluate the ability of micro-CT to evaluate disease progression 
longitudinally in a mouse model of myocardial infarction, and to evaluate 
inter- and intra-observer variability; 
2. To determine the suitability of a new blood-pool contrast agent for use in 
cardiac imaging; 
3. To determine the x-ray dose effects of a typical longitudinal cardiac micro-
CT study on the pulmonary and cardiac tissue in mice;  
4. And finally, to apply this cardiac micro-CT technique in an evaluation of 
conductance catheter effects on the mouse heart. 
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1.7 Thesis Outline 
This thesis examines the use of rapid cardiac micro-CT to both quantitatively and 
qualitatively evaluate cardiac structure and function in mouse models.  In particular, each 
of the objectives outlined above is addressed in one of the following chapters.   
 
1.7.1 Chapter 2 
Chapter 2 demonstrates the ability of micro-CT to evaluate cardiac disease 
progression over a 4-week period.  A mouse model of myocardial infarction (MI) was 
chosen, and was scanned at baseline, prior to the ligation of the coronary artery that 
produced the MI, as well as weekly following the surgery.  These results were compared 
to a sham group, as well as to hemodynamic data obtained using a conductance catheter.  
The inter- and intra-observer variability of micro-CT measurements was also evaluated.  
Cardiac micro-CT was effective in quantitatively measuring changes in both LV volume 
and ejection fraction in the MI mice; these trends were mirrored in the hemodynamic 
measurements, however the absolute values obtained with the conductance catheter were 
quite different from the micro-CT values, suggesting that the catheter was not the most 
appropriate methodology for evaluating volume.  This formed the basis for the study 
presented in Chapter 5. 
 
1.7.2 Chapter 3 
An important element of cardiac micro-CT is the use of a contrast agent, 
necessary for visualizing the heart.  A new blood-pool contrast agent had become 
available with a higher iodine concentration than previous products, which offered the 
possibility of using a smaller injected volume and therefore less risk of disrupting the 
hemodynamics of the mouse.  Chapter 3 examines the new agent from the perspective of 
its use in cardiac studies; overall, the contrast agent provided excellent enhancement, and 
seemed easier for the mouse to clear than previous agents.  It also displayed a unique 
property: enhancement of the myocardium several hours after injection.  Given the 
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inherent low soft tissue contrast of micro-CT, the enhancement witnessed offers 
intriguing possibilities in the evaluation of myocardial function. 
 
1.7.3 Chapter 4 
Chapter 4 investigates a frequent concern of using micro-CT, especially in 
longitudinal studies: the x-ray dose delivered to the mice, and the potentially adverse 
effects on cardiac and pulmonary tissue.  A typical cardiac micro-CT study was modeled, 
with the mice being scanned weekly over a period of six weeks.  At the end of the study, 
both the heart and lungs were evaluated on the CT images for any changes indicating 
adverse effects, and more importantly cardiac and pulmonary tissue were histologically 
evaluated for evidence of early radiation damage at a cellular level.  Overall, there were 
no indications of x-ray damage induced during the micro-CT study in either the images or 
the histology slides, indicating that micro-CT can be safely used in longitudinal studies 
without concerns of any negative consequences related to the radiation dose. 
 
1.7.4 Chapter 5 
Finally, in Chapter 5, cardiac micro-CT was employed to evaluate the 
conductance catheter methodology first introduced in Chapter 2.  Other studies have been 
performed indicating that conductance catheter volume measurements can be grossly 
underestimated; this study sought to confirm this, but also to determine if the invasive 
nature of catheterizing the heart is causing any unintended damage to the cardiac tissue, 
possibly affecting the functional measurements.  The rapid nature of the cardiac micro-
CT technique of this thesis enabled scans to be performed simultaneously with 
conductance catheter measurements, allowing direct comparison of volume 
measurements between the two techniques to be carried out, as well as high-resolution 
visualization of the catheter in place in the LV.  This study confirmed that the volume 
measurements of the catheter were underestimated, and more interestingly that the 
catheterization caused LV enlargement in almost half the mice of the study.  Although 
not enough to create a statistical significance of 0.05, the results suggest that the catheter 
is causing some damage to the heart, which should be further explored.
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2 Longitudinal Follow-up of Cardiac Structure and 
Functional Changes in an Infarct Mouse Model using 
Retrospectively Gated Micro-computed Tomography 
 
The content of this chapter is adapted from “Longitudinal follow-up of cardiac 
structure and functional changes in an infarct mouse model using retrospectively gated 
micro-computed tomography”, published in Investigative Radiology, vol 43 (7) July 
2008, by Sarah A. Detombe, Nancy L. Ford, Fuli Xiang, Xiangru Lu, Qingping Feng, and 
Maria Drangova. 
 
2.1 Introduction 
Mouse models have become increasingly important in the study of cardiovascular 
diseases.  Detailed information about the genome has allowed models to be developed 
that either overexpress or underexpress specific genes to study their contribution to the 
pathophysiology of a given cardiovascular disease process. 
The established method for studying cardiac function in mouse models involves 
the analysis of pressure-volume relationships measured using a pressure-conductance 
catheter.  By inserting a catheter into the left ventricle (LV) and recording both pressure 
and volume readouts, heart function can be determined, most notably by detecting small 
alterations in myocardial contractility.1  However, due to the inability of pressure-volume 
conductance devices to continuously measure parallel conductance, LV volume is often 
underestimated.2, 3  The procedure is also invasive, resulting in a terminal experiment, 
and requires an individual with specialized surgical skill to produce consistent data. 
Multiple imaging modalities have been developed that have the capability of 
measuring cardiac structure and function in the mouse; these are non-invasive procedures 
that allow individual animals to be tracked over the entire study.  Commonly used 
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techniques are magnetic resonance imaging (MRI)4-10 and echocardiography,11-16 both of 
which have been used to successfully measure LV function.  MR images typically require 
long scan times and are usually acquired with large slice thicknesses (approximately 1 
mm).  Accurate heart function measurements also require that the scans be acquired in 
the short axis orientation, which can be difficult to define in diseased hearts,5 although a 
recent study17 has described a method of acquiring three-dimensional (3D) MR images 
with 200-#m isotropic voxels, which may alleviate this limitation. 
 Echocardiography is frequently used because it is easy to operate, can provide 
real-time images, and can measure velocity.  Although two-dimensional (2D) imaging is 
available (and 3D imaging has been demonstrated18), cardiac function is most frequently 
measured from M-mode images.12, 19-21  Estimating cardiac function from M-mode and 
2D images relies on geometrical assumptions and is highly user-dependent. 
In recent years, micro-computed tomography (micro-CT) techniques have 
emerged, capable of overcoming the challenges of imaging the mouse heart such as the 
fast heart rate (about 500 beats per minute under anesthetic) and the small size (5 mm 
across the short axis of the ventricle).  Badea et al.22 demonstrated a prospectively gated 
micro-CT technique that acquires 3D images with 90-µm isotropic voxels, and a scan 
time of approximately 10 minutes for each cardiac phase, which has recently been 
applied to an infarct mouse model.23  This technique, however, requires that the animals 
be intubated, and mice are scanned in a vertical position, which may disrupt cardiac 
function.24  
Retrospectively gated micro-CT imaging techniques have been recently 
developed that enable the acquisition of 3D images throughout the cardiac cycle in free-
breathing mice.25, 26 The methodology outlined by Drangova et al.25 has multiple 
advantages, including a short scan time (<1 minute), and high resolution (150-µm 
isotropic voxel spacing).  Retrospectively gated micro-CT can provide both quantitative 
and qualitative assessment of cardiac function that, as a result of the minimal anesthetic 
required and the short scan times, offers nominal disruption to the animal.  In this study, 
we follow heart failure progression in an infarct mouse model over four weeks to 
demonstrate the utility of this technique when investigating a mouse model of 
cardiovascular disease.  To the best of our knowledge, this is the first study using 
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retrospectively gated micro-CT to follow cardiac remodeling in each individual mouse 
over time following the induction of an infarct. 
 
2.2 Methods 
All studies performed were approved by the Animal Use Subcommittee of the 
University Council on Animal Care at The University of Western Ontario.  Fourteen male 
C57BL/6 mice, approximately 25 weeks old and weighing 32 ± 3 g, were split into two 
groups; one group underwent ligation of the left coronary artery, and the other group 
underwent sham surgery. Mice were scanned at baseline (before surgery), and weeks 1, 2, 
3, and 4 post-surgery; 3 of the sham mice and 3 of the myocardial infarction (MI) mice 
did not receive a scan at baseline and week 2 post-surgery. 
 
2.2.1 Induction of Myocardial Infarction 
Surgery was performed as previously described.27  Animals were anesthetized 
with  ketamine (50 mg/kg) and xylazine (12.5 mg/kg) delivered intraperitoneally.  The 
mice were then intubated and artificially ventilated.  A left thoracotomy was performed, 
exposing the LV wall; the left coronary artery was ligated by positioning a suture 
between the pulmonary artery out-flow tract and the left atrium.  Sham-operated animals 
underwent the same surgical procedure, including positioning of the suture, but it was not 
tightened to ligate the artery.  To decrease acute mortality after ligation, atropine (0.05 
mg s.c.) was administered before surgery to decrease airway excretion.  Following 
surgery, mice were treated with antibiotic agent (oxytetracycline, 200 mg/L) via drinking 
water for 3 days; analgesic (0.03 mg/kg burprenorphine s.c.) was administered to relieve 
pain.  
 
2.2.2 Animal Preparation for Scanning 
Mice were anesthetized with 1.5% isoflurane in O2.  Approximately 5 minutes 
prior to scanning, the animals were injected intravenously with 0.01 mL/g Fenestra VC 
28 
 
(50 mg I/mL; Advanced Research Technologies, Inc., St. Laurent, Quebec, Canada), an 
iodinated blood-pool contrast agent that enhances the vasculature for several hours.28  
The dose given in this study was half the dose administered by Drangova et al.25 and 
Badea et al.22  This dose of contrast agent was selected to reduce the volume injected into 
the mouse, and pilot experiments demonstrated that sufficient contrast was achieved at 
this dose level.28  Three neonatal ECG electrodes (2269T, 3M Health Care, St. Paul, MN) 
were attached to the paws, and the animal was placed prone on a respiratory monitoring 
bed connected to a pressure transducer, which translates diaphragm motion to a recording 
of a respiratory wave signal.29  Physiological signals were recorded using a physiological 
monitoring and triggering system (BioVet, m2m Imaging Corp., Newark, NJ, USA).  
Temperature was monitored and maintained between 36°C and 37°C for all scans.  The 
mice were not intubated and remained free-breathing during the experiment.   
 
2.2.3 Image Acquisition and Retrospective Gating 
Images were acquired using a volumetric cone-beam micro-CT scanner (Locus 
Ultra, General Electric Healthcare, London, ON, Canada), equipped with a flat-panel 
detector and clinical x-ray tube mounted on a slip-ring gantry, which enables continuous 
dynamic acquisition of x-ray projections.  Projection images were acquired at 80 kVp and 
50 mA over a field of view measuring 14 cm (transaxial) x 5.4 cm (longitudinal).  To 
enable retrospective gating, projections were acquired over 10 rotations (5 seconds per 
rotation, 416 projection images per rotation at a rate of 12 milliseconds/projection) for a 
total scan time of 50 seconds.  Entrance dose for a 50 second scan was previously 
calculated to be 0.28 Gy.25 
Retrospective gating and reconstruction of acquired projection images is 
described in detail by Drangova et al.25  Briefly, for each phase of the cardiac cycle 
projections were selected, from those acquired, based on the recorded respiratory and 
ECG signals; only projections occurring during end expiration and a predetermined 
cardiac window (12 ms) were used to reconstruct the 3D image for the selected cardiac 
phase.  For this study 9-13 3D images were reconstructed per cardiac cycle, depending on 
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the heart rate.  All images were reconstructed on a 256 x 256 x 360 matrix with isotropic 
voxel spacing of 150 µm x 150 µm x 150 µm.30 
 
2.2.4 Image Analysis 
Image analysis was performed using MicroView software (version ABA 2.2, 
General Electric Healthcare, London, ON, Canada).  Images were reoriented to align with 
the long and short axes of the heart.  To calculate LV volume, an automated seeded 
region-growing algorithm was used.  First, a threshold level that separated the blood from 
the myocardium in the images was identified automatically31 by drawing small regions of 
interest containing equal parts of tissue and blood.  Because of small differences in the 
concentration of contrast agent in each mouse at scan time, a separate threshold value 
was defined for each animal at each time point.  Automatic region growing was then used 
to segment the LV chamber from the myocardium; the region growing was terminated at 
the aortic valve, with manually drawn contours limiting the segmentation near the valve 
where the wall of the ventricle became too thin to constrain the region-growing 
algorithm.  The aortic valve was visually located in the short axis plane and the 
anatomical location was confirmed in the coronal view.  LV volume was calculated based 
on the segmented region and the known voxel size.  Systolic and diastolic images were 
identified by calculating LV volume throughout the cardiac cycle to determine the frames 
that had minimum and maximum volumes.  Once the end-systolic volume (ESV) and the 
end-diastolic volume (EDV) were determined, stroke volume (SV = EDV – ESV), 
ejection fraction (EF = SV / EDV), and cardiac output (CO = SV * heart rate) were 
calculated. 
 
2.2.5 LV Mass Measurements 
LV mass was determined from the CT images for all mice in weeks 1 and 4.  A 
contour was manually drawn around the outer edge of the LV, using the aortic valve as 
an upper boundary, and the LV wall was automatically segmented within the contoured 
region using the threshold previously calculated for LV chamber volume determination.  
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The resulting myocardium volumes were multiplied by the density of myocardium (1.05 
g/ml) in order to calculate LV mass. 
 
2.2.6 Reproducibility 
The reproducibility of the technique was determined in terms of inter-observer, 
intra-observer, and intra-subject variability. For inter-observer variability, the systolic and 
diastolic images of 13 mice (7 sham and 6 MI), acquired at weeks 1 and 4 post-surgery, 
were analyzed by three independent operators.  Intra-observer variability was determined 
by one individual analyzing these same images three times.  For intra-subject variability 
determination, two sham and three MI mice were each scanned three times, following 
repositioning, at the final scan time-point (4 weeks). 
 
2.2.7 Hemodynamic Measurements 
Hemodynamic measurements were performed as previously described:27 
following scanning at the 4-week time-point, mice were anesthetized with sodium 
pentobarbital (50 mg/kg IP), and a Millar pressure conductance catheter (model SPR-839, 
1.4 F) was inserted into the LV via the right carotid artery to measure LV pressures, 
volumes, and heart rate. Data were recorded by a PowerLab Chart program 
(ADInstruments Inc, Colorado Springs, CO).  All hemodynamic parameters were 
analyzed by a PVAN software (Millar Instruments, Houston, TX).  Following 
hemodynamic analysis, hearts were excised, fixed with 10% formalin, then sliced and 
stained with hematoxylin and eosin. 
 
2.2.8 Statistical Analysis 
Data are presented as mean ± SD for continuous variables.  Two-way ANOVA 
was performed, using Prism 4 (GraphPad Software, Inc., San Diego, CA), to compare 
differences between sham and MI groups over time for each of the cardiac functional 
parameters (ESV, EDV, SV, EF, CO); Bonferroni post-tests were also performed.  
Variabilities were calculated as the standard deviations of the means of multiple 
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measurements.  Power tests were performed using StatMate 2 (GraphPad Software, Inc., 
San Diego, CA).  Results were considered statistically significant at p<0.05. 
 
2.3 Results 
Retrospectively gated micro-CT images were successfully acquired in all 14 mice; 
one mouse was excluded from analysis retrospectively due to unsuccessful ligation of the 
coronary artery, which failed to create an infarct.  On average, the contrast agent 
increased the attenuation of the blood pool to 331 ± 57 HU, compared to the myocardial 
tissue (76 ± 27 HU); the average threshold that separated the blood pool in the LV from 
the myocardium was 255 ± 54 HU.  Out of 416 possible projections, an average of 325 ± 
42 projections were available to reconstruct an image at each point in the cardiac cycle.  
The average noise in the myocardium was previously measured to be 36 ± 4.6 HU.25 
Figure 2.1 shows representative long- and short-axis images acquired at week 4 
post-surgery in a sham-operated (Fig. 2.1 a, c) and a MI (Fig. 2.1 b, d) mouse.  The 
images were extracted from the 3D images reconstructed at the selected phase of the 
cardiac cycle.  The infarcted heart (Fig. 2.1b) is distended, with a thinning of the wall in 
the apex of the ventricle, representing the infarct (noted with arrows).  Note the entire 
heart of the MI mouse appears to be enlarged.  Figure 2.2 shows the histology of the LV 
from an MI (a) and a sham (b) mouse at week 4 post-surgery.  The enlarged LV from the 
MI mouse, and the area of infarction, are clearly demonstrated. 
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Figure 2.2:  Histological slides of the LV from an MI (a) and a sham (b) 
mouse, stained with hematoxylin and eosin.  The infarct is identified by arrows 
in (a). 
 
 
Figure 2.1: Long (a, b) and short (c, d) axis images of the 
mouse heart in diastole of a sham-operated (a, c) and MI (b, d) 
mouse.  These images represent 150-µm sections taken from the 
reconstructed 3D volumes.  The in-plane voxel spacing is also 
150 µm.  Note that the entire heart of the MI mouse is enlarged, 
indicating the global effects of the infarct.  The infarct is 
evident in the thinned wall in the apex of the LV, below the 
arrows. 
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Figures 2.3a (sham-operated) and 2.3b (infarct model) represent long- and short-
axis views of an individual mouse heart in diastole (i, iii) and systole (ii, iv).  Apparent 
from these images are the differences in size between diastole and systole when 
comparing sham and MI animals.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 2.4 and 2.5 illustrate differences in cardiac morphology of a heart in 
diastole in a sham-operated and MI mouse, respectively, over the course of experiment.  
The size and shape difference between baseline and the final time point is also 
 
Figure 2.3:  Long and short axis images of a 
sham-operated mouse heart (a) and a MI 
mouse heart (b) in diastole (i, iii) and systole 
(ii, iv).  The images were acquired 4 weeks 
post surgery.  Note the obvious reduction in 
contraction of the infarcted heart (b) 
compared to the sham-operated heart (a). 
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demonstrated in the 3D representation of the LV chambers of a MI mouse shown in 
Figure 2.6.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4:  A series of long and short axis images showing weekly changes in a 
sham-operated mouse heart in diastole.  Time points represented are: baseline, 1 week 
post-surgery, 2 weeks post-surgery, 3 weeks post-surgery, and 4 weeks post-surgery. 
 
 
Figure 2.5:  A series of long and short axis images showing weekly changes in a MI 
mouse heart in diastole.  Time points represented are: baseline, 1 week post-surgery, 2 
weeks post-surgery, 3 weeks post-surgery, and 4 weeks post-surgery.  
 
 
Figure 2.6:  3D representation (isosurface) of the LV overlaid on 
images of an infarcted heart at baseline (a) and week-4 post infarction 
(b).  The isosurface models were generated from wire-frame meshes 
created following an intensity-based region growing operation. 
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One of the main advantages of using a non-invasive imaging technique includes 
the ability to quantify changes in cardiac function in individual animals over time.  Figure 
2.7(a-e) illustrate the functional parameters calculated for individual mice and Fig. 2.7f 
tracks the measured heart rates.  Note the small weekly changes observed in individual 
mice in ESV (Fig. 2.7a) and EDV, (Fig. 2.7b), as well as in the functional parameters 
calculated from the volumes.  
 
Figure 2.7:  Measured cardiac functional parameters tracking individual mice over the 
5-week experiment.  Graphs represent systolic volume (a), diastolic volume (b), stroke 
volume (c), ejection fraction (d), cardiac output (e), and heart rate (f).  Sham-operated 
mice are represented by blue solid lines and squares; MI mice are represented by red 
dashed lines and triangles.  Note that each symbol represents the measurements of an 
individual mouse at each time point. 
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Average values of the functional parameters for each week were also calculated and are 
listed in Table 2.1.   
 
Table 2.1. Weekly Average Functional Parameters of Sham-operated and MI Groups  
 Functional Parameter 
 ESV (µl) EDV (µl) SV (µl) EF (%) CO (ml/min) 
Baseline      
Sham (4) 38.5 ± 14.1 65.1 ± 14.7 26.5 ± 1.1 42.4 ± 9.5 12.9 ± 1.0 
MI (3) 46.5 ± 8.2 81.0 ± 14.7 34.5 ± 6.5 42.5 ± 1.0 16.5 ± 3.4 
p-value ns ns ns ns ns 
      
Week 1      
Sham (7) 26.1 ± 9.7 58.6 ± 10.9 32.4 ± 6.3 56.2 ± 10.2 15.0 ± 3.1 
MI (6) 97.5 ± 33.3 135.2 ± 29.6 37.8 ± 15.9 29.0 ± 13.8 18.8 ± 6.4 
p-value 0.0002 <0.0001 ns 0.0018 ns 
      
Week 2      
Sham (4) 22.3 ± 7.9 57.1 ± 14.5 34.7 ± 7.0 61.8 ± 6.2 18.3 ± 3.0 
MI (3) 149.4 ± 27.1 177.9 ± 31.2 28.5 ± 7.1 16.1 ± 3.3 14.5 ± 2.8 
p-value 0.0003 0.0009 ns <0.0001 ns 
      
Week 3      
Sham (7) 30.5 ± 10.5 68.9 ± 8.3 38.4 ± 7.4 56.3 ± 12.7 17.3 ± 4.1 
MI (6) 137.0 ± 38.4 171.5 ± 36.2 34.4 ± 8.5 21.1 ± 7.8 17.3 ± 4.1 
p-value <0.0001 < 0.0001 ns 0.0001 ns 
      
Week 4      
Sham (7) 22.7 ± 6.5 61.3 ± 9.7 38.5 ± 5.5 63.3 ± 6.6 19.6 ± 2.4 
MI (6) 139.3 ± 45.4 177.5 ± 34.6 38.2 ± 14.5 23.1 ± 11.7 19.0 ± 6.5 
p-value <0.0001 < 0.0001 ns < 0.0001 ns 
Values are means ± SD; ESV, end-systolic volume; EDV, end-diastolic volume; SV, 
stroke volume; EF, ejection fraction; CO, cardiac output; numbers in brackets represent 
no. of animals 
  
 
Significant differences (p<0.0001) were observed between the sham and MI groups for 
ESV, EDV, and EF, as demonstrated by 2-way ANOVA; also, ESV and EDV showed 
significant differences over time (p<0.0001).  Bonferroni post-tests confirmed that 
significant differences occurred between each group at each time point.  SV and CO did 
not show significant differences either between the surgery groups or over time (p>0.1 
for all tests).  Power tests determined there was sufficient power (>80%) to detect 
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expected differences18, 23, 32 in ESV, EDV, and EF. Power calculations for SV and CO 
showed insufficient power to detect differences of 20%, which have been previously 
observed between sham and MI mice.33  
LV mass measurements calculated from the CT images are listed in Table 2.2.  
Significant differences were seen between the sham and MI groups in both weeks 1 and 4 
(p=0.012 and 0.008, respectively); changes in LV mass between weeks 1 and 4 were 
insignificant for both the sham (p=0.60) and MI (p=0.08) groups. 
 
 
 
Table 2.2. Average LV mass measurements for Sham and MI groups in Weeks 1 and 4 
Post-Surgery 
 LV mass (mg)  
Group Week 1 Week 4  
Sham mice (n=7) 91 ± 14 101 ± 14 p=ns 
MI mice (n=6) 122 ± 23 136 ± 24 p=ns 
    
 p=0.012 p=0.008  
Values are means ± SD; n, no. of animals 
 
 
 
Variability studies showed excellent reproducibility of measurements between 
individuals, and by the same individual (Table 2.3).  Intrasubject measurements also 
show good reproducibility, with variation in volumes of infarcted hearts being slightly 
higher than variations in sham-operated hearts (Table 2.3).  Overall, the variability due to 
image analysis by the same or different observers was low (on average, less than ±0.85 
and ±1.8 #l, respectively) and was lower than the intra-subject variability in LV volumes 
(±2.8 #l on average).  
Hemodynamic measurements made in week 4 (Table 2.4) were compared to 
measurements made from CT images. Comparison of the ejection fractions measured 
using the two techniques showed no significant differences for either the sham or the MI 
groups (p > 0.1). 
 
38 
 
 
Table 2.3. Average Inter-observer, Intra-observer, and Intra-subject Variabilities of 
Systolic and Diastolic Volumes 
 Sham mice MI mice 
 Systole (µl) Diastole (µl) Systole (µl) Diastole (µl) 
Inter-observer (n=7) (n=7) (n=6) (n=6) 
Week 1 1.9 ± 1.6 1.6 ± 1.0 1.8 ± 2.2 2.6 ± 1.6 
Week 4 1.0 ± 0.6 1.3 ± 0.5 1.7 ± 1.4 1.7 ± 1.1 
     
Intra-observer (n=7) (n=7) (n=6) (n=6) 
Week 1 0.9 ± 0.8 0.6 ± 0.3 0.8 ± 0.7 0.9 ± 0.7 
Week 4 0.5 ± 0.5 0.8 ± 0.8 0.8 ± 0.5 1.4 ± 0.9 
     
Intra-subject (n=2) (n=2) (n=3) (n=3) 
Week 4 0.19; 1.32 1.24; 1.73 3.6 ± 0.2 5.5 ± 0.8 
Values are means ± SD, excepting Intra-subject group where exact values are listed for 
each sham mouse; n, no. of animals. 
 
 
Table 2.4. Comparison of CT-based Measurements and Hemodynamic Measurements at 
Four Weeks Post Surgery 
Functional 
Measurements 
CT Measurements Hemodynamic Measurements 
Sham (n=7) MI (n=6) Sham (n=7) MI (n=6) 
EDV (µl) 61 ± 10 178 ± 35 26 ± 8 29 ± 10 
ESV (µl) 23 ± 7 139 ± 45 12 ± 6 21 ± 7 
SV (µl) 39 ± 6 38 ± 15 14 ± 7 7 ± 5 
EF (%) 63 ± 7 23 ± 12 54 ± 20 26 ± 15 
CO (ml/min) 20 ± 2 19 ± 7 5 ± 3 2 ± 1 
+dP/dtmax(mmHg.s) - - 7321 ± 948 3456 ± 1032 
-dP/dtmin(mmHg.s) - - 5969 ± 1070 3102 ± 861 
Heart rate (bpm) 511 ± 30 505 ± 32 360 ± 80 281 ± 48 
Values are means ± SD; n, no. of animals; ESV, end-systolic volume; EDV, end-diastolic 
volume; SV, stroke volume; EF, ejection fraction; CO, cardiac output; +dP/dtmax, 
maximal rate of LV pressure increase; -dP/dtmin, maximal rate of LV pressure decline. 
 
2.4 Discussion 
This study is the first to demonstrate longitudinal tracking of quantitative cardiac 
functional parameters in individual mice using a dynamic micro-CT scanner.  Recently 
published data demonstrated, in healthy mice, that retrospectively gated micro-CT rapidly 
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and reproducibly acquires images that can be used to quantify cardiac function.25  
Retrospectively gated micro-CT takes advantage of the scanning capabilities of a 
volumetric CT scanner equipped with a 2D detector mounted on a slip-ring gantry, 
making continuous image acquisition possible.  Contrast between blood and myocardium 
is provided by a tri-iodinated blood-pool contrast agent, which provides excellent contrast 
for several hours.28  The entrance dose of 0.28 Gy per scan, although higher than the dose 
reported for clinical diagnostic CT thorax exams,34, 35 is not anticipated to have a 
detrimental effect on cardiovascular physiology in the mouse.25, 36, 37  The advantages of 
this micro-CT scanning method include: 1) scan times of less than one minute to 
characterize cardiac function over the entire cycle, by generating a series of high-
resolution (150 #m isotropic voxels) 3D images; 2) the capability of scanning free-
breathing animals in a prone position and; 3) the ability to scan animals under very light 
anesthesia (typically provided by isoflurane, which has little effect on cardiac function 
when compared to injectable anesthetics38-41). 
This current study endeavored to demonstrate that retrospectively gated micro-CT 
precisely identifies the differences in heart function between infarcted and control mice 
and can follow these differences longitudinally in individual mice.  Differences in cardiac 
structure were clearly identifiable in the 3D images (Fig. 2.1), where infarcted mice 
demonstrated drastically enlarged hearts and thinned walls in the apical 40% of the LV 
(arrows Fig. 2.1b); the enlarged right ventricle and atria illustrate the widespread effect of 
the infarct.  Histological slides of the LV from an MI mouse and a sham mouse (Fig. 2.2) 
confirm the enlarged size and the area of infarction identified on the CT images.  
Quantitative differences in LV size and function were also observed between the sham 
and MI groups at all time points in the study (Table 2.1).  Significant differences were 
observed for systolic and diastolic LV volumes, and for ejection fraction between the two 
groups at all time points post surgery.  Significant increases in LV size with time over the 
course of the experiment were also observed in the MI mice (Fig. 2.7 a, b). 
Baseline EF values were lower than expected for healthy mice.17, 23, 32  It was 
necessary to transport the mice between facilities for the baseline scans, whereas for 
weeks 1-4, the animals were housed in the same building as the scanner; at the time, this 
was an unavoidable complication of the study.  The transportation may have caused a low 
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level of stress in the mice, resulting in abnormally low ejection fractions.42, 43  The 
unexpected results highlight an advantage of this micro-CT technique – the ability to 
closely track perturbations in the animal’s health during a study that would have 
otherwise been undetected.  These results also suggest that transportation of mice prior to 
imaging, or other study that measures physiological function, should be avoided on the 
day of the procedure.  
On average, the measured values for CO agreed with previously reported results 
at the experimental end point.32, 33  The lack of significant differences in SV and CO 
between the sham and MI groups is potentially attributable to the limited time frame over 
which the experiment was carried out; although the EF was clearly reduced in the MI 
mice, the compensatory increase in heart size may be responsible for the maintenance of 
a relatively constant stroke volume, and therefore, cardiac output.  Had the study 
continued past week four, decreases in stroke volume and cardiac output are likely to 
have been measured.  Additionally, it’s possible that a decrease in stroke volume may 
occur early in the first week, before compensatory LV dilation takes place, however no 
scans were performed during that time period in this study.  Any future studies evaluating 
MI disease progression in mice should take this into account.  Regarding the 
measurements recorded during the time frame of this study, similar increases in cardiac 
dimension were reported by Yang et al.44 who used echocardiography to measure LV 
diastolic shortening in different groups of infarcted mice, which were sacrificed at each 
experimental time point. 
An important advantage of tracking the same animal over the entire course of an 
experiment using a non-invasive imaging technique is that small changes in individual 
animals are not lost in the averaging process of a population of mice; a baseline scan can 
act as the ideal control for the animal at later time points, and paired statistical analyses 
can be performed.  This advantage is seen qualitatively in the series of images in Fig. 2.5, 
which depict the gradual cardiac remodeling as it occurs over the 4 weeks, and 
quantitatively in Fig. 2.7. 
LV mass measurements are an important element of tracking changes to the 
myocardium.  In this study we determined LV mass in both groups of mice at week 1 and 
week 4 (Table 2.2).  A significant difference in mass between the sham and MI groups 
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was observed, confirming that hypertrophy had occurred following the induction of the 
infarct; there was no significant difference between the weeks, indicating that the 
observed hypertrophy took place during the first week after surgery. 
The variability studies demonstrated that overall the quantitative measurements 
were highly reproducible.  Because most of the analysis was automatic, both inter- and 
intra-observer variability depended mostly on the variability of contour placement in the 
regions near the base of the LV.  The excellent intra-subject variability (repeated scans on 
the same mouse in the same scanning session) provided further support that the low EF 
measurements made at baseline reflect true physiological changes.  The intra-subject 
variability was slightly higher for the MI mice than the sham-operated mice; this 
difference was attributed to the rounded shape of the LV in infarcted mice making the 
identification of the base of the heart more subjective.  The ability to reorient the high-
resolution 3D isotropic images to align with the long and short axis of the hearts 
improves the ease of identifying the base of the heart, where manually drawn contours 
were required.  This is in contrast to most MRI and echocardiography experiments, where 
the images must be acquired in the short axis of the heart, which can be difficult, 
especially in remodeled hearts.5  Note that retrospective reorientation of MR or 
echocardiographic images acquired with thicker slices (approximately 1 mm) or large 
inter-slice spacing (in the case of 3D echo) is typically not possible; the voxels are not 
isotropic and reorienting would introduce interpolation effects. 
 
2.4.1 Limitations 
One of the limitations of this study was the inability to directly compare CT-
derived measurements with the catheter-derived LV volume measurements, due to the 
accepted underestimation and large variability of volume measurements made invasively 
by pressure-conductance catheters.2, 3  The use of different anesthetics when comparing 
micro-CT to catheterization was not ideal, however our aim in using inhalation 
anesthetics during CT scanning was to emphasize the low invasiveness of the CT 
approach.  Using an injectable anesthetic would have made controlling the depth of 
anesthesia difficult, as well as increasing the invasiveness of the procedure.  In addition, 
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the hemodynamic measurements were made on the same day as the scanning occurred, 
but following the administration of a second (injectable) anesthetic agent, which resulted 
in further lowering the heart rates during the procedure.  The number of animals in the 
study was small, but important functional parameters could be followed over time with 
sufficient statistical power, indicating the effectiveness of the technique to follow cardiac 
remodeling. 
 
2.4.2 Conclusion 
The present work demonstrates that retrospectively gated micro-CT precisely 
defines the differences in heart function and volume between sham and MI animals.  This 
methodology has the ability of following individual animals over the entire study, 
enabling the tracking of small changes in cardiac remodeling that may be not be evident 
when averaging a group of mice.  Reproducibility studies show low variability during 
analysis (inter- and intra- observer).  The rapid acquisition of dynamic 3D images also 
makes the technique highly suitable for large throughput phenotyping studies.  
Furthermore, the retrospectively gated micro-CT technique can be combined with the 
injection of a conventional contrast agent, as suggested by Nahrendorf et al.,23 to identify 
areas of infarction, where the contrast agent extravasates over time.  Ultimately, 
retrospectively gated micro-CT has the potential to become an important tool for 
following disease progression and disease regression, following the administration of 
various experimental therapeutic agents. 
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3 Evaluation of eXIA 160 Cardiac-related 
Enhancement in C57BL/6 and BALB/c mice using 
Micro-CT 
 
The content of this chapter has been adapted from “Evaluation of eXIA 160 
cardiac-related enhancement in C57BL/6 and BALB/c mice using micro-CT”, 
published in Contrast Media and Molecular Imaging vol 7 (2) March 2012, by Sarah 
A. Detombe, Joy Dunmore-Buyze, and Maria Drangova. 
 
3.1 Introduction 
The use of small animal models to study a variety of diseases has driven the 
development of imaging devices capable of studying structural and functional changes in 
organ systems on a small scale.  Micro-computed tomography (micro-CT), a non-
invasive imaging technique capable of producing images with high-resolution isotropic 
voxels, measures the attenuation of x-rays passing through the subject.  It is adept at 
providing excellent information regarding skeletal structure, but soft tissues in the body 
are very similar in density and require a contrast agent of radio-opaque material to enable 
soft tissue differentiation.  Specifically, evaluating cardiovascular function requires a 
contrast agent to distinguish the blood in the heart chambers from the myocardium. 
Clinical contrast agents in use, such as iohexol and iopamidol, have high 
concentrations of organically-bound iodine that provide excellent contrast between blood 
and tissue, but are quickly cleared via glomerular filtration.1  Scans measuring cardiac 
function in small animal models require longer scan times with consistent contrast, and 
an optimal protocol using these clinical agents can be challenging to develop. 
An iodinated triglyceride emulsion (ITG) was designed and developed 
specifically to visualize liver tumors;2,3 as the ITG is preferentially taken up by the 
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hepatocytes tumors are visualized as hypodense regions.  However, this contrast was also 
rapidly cleared from the bloodstream.  In 1998, Weichert et al. reported the development 
of an ITG that also contained polyethylene glycol (ITG-PEG).4  The PEG molecules 
prevented rapid uptake of the ITG by the liver, due to steric hindrance, and as a result, the 
contrast agent remained in the blood-pool and provided vascular enhancement for several 
hours.  Marketed as Fenestra VC, this contrast agent was subsequently used in multiple 
studies reporting the development and use of cardiac-gated micro-CT to measure cardiac 
function in mice,5-9 vascular micro-imaging,10 as well as for characterizing liver tumor 
size.11, 12 
Recently, a new preclinical blood-pool contrast agent has been developed: eXIA 
160 is an aqueous colloidal poly-disperse contrast agent with a high concentration of 
iodine (160 mg I/mL) compared to Fenestra VC (50 mg I/mL), creating strong contrast 
between blood and tissue with a low injection volume.  This is especially beneficial when 
monitoring cardiac function in mice, as their small blood volume limits the volume that 
can be safely injected without adverse hemodynamic effects.  Although enhancement of 
the liver and spleen using eXIA 160 has been reported,13 and eXIA 160 was recently used 
in a study investigating vessel imaging,14 a blood-pool enhancement time-course and the 
related implications for measuring cardiac function have not yet been characterized.  
Transgenic mice have been used extensively in cardiovascular research to 
investigate a variety of cardiovascular diseases, but the genetic strain of the mice used is 
rarely considered in physiological studies.15  However, several recent studies have 
highlighted the importance of considering genetic strain when investigating disease 
models, as similar procedures can provoke opposite responses in different strains.16, 17  It 
will therefore be useful to determine if any strain-related differences in contrast agent 
uptake and elimination occur between the C57BL/6 and BALB/c strains, two of the most 
commonly used strains in cardiac research.15 
In this study, a high-resolution volumetric micro-CT scanner was used to evaluate 
whole-body tissue enhancement of eXIA 160 in both C57BL/6 and BALB/c strains over 
a 48-hour period.  Our objective was to determine the optimal use of this contrast agent 
during cardiac function studies in mice and if strain-related differences in enhancement 
are occurring against different genetic backgrounds. 
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3.2 Methods 
3.2.1 Animal Preparation 
All animal studies were carried out in accordance with the regulations set out by 
The University of Western Ontario’s Council on Animal Care.  Six C57BL/6 male mice, 
22-24 g, and six BALB/c male mice, 22-24 g (Jackson Laboratories, Bar Harbor, ME), 
were anesthetized with 1.5% isoflurane in O2 via a nose cone placed on the snout of the 
animals, which allowed  them to freely breathe the isoflurane; a respirator was not 
utilized and intubation was not necessary.  Mice were placed prone on the scanner bed 
and kept warm with infrared lamps, previously shown to maintain body temperature near 
37°.8, 9  Following a control scan, acquired prior to contrast administration, 5 µL/g body 
weight of eXIA 160 (Binitio Biomedical Inc, Ottawa, ON, Canada) was slowly injected 
into the anesthetized animals over a 2-minute period via tail vein.  In addition to the 
precontrast scan, animals were also scanned at 5, 15, 30, 45, 60 min, and 2, 4, 8, 12, 24, 
and 48 hr post injection.  Numerous scans were performed in the first hour post-injection, 
as previous studies indicated rapid elimination from the blood-pool within the first 
hour.13  Mice were kept anesthetized for the first hour of scanning, then re-anesthetized 
for each subsequent scan.  Saline ( 0.5 ml ) was administered subcutaneously following 
the 60 min. scan to aid in recovery. 
 
3.2.2 Scan Acquisition and Reconstruction 
Scans were performed using the GE Locus Ultra (GE Healthcare, London, ON, 
Canada), a scanner comprised of a clinical x-ray tube and a 1024 x 1024 flat-panel 
detector mounted on a slip-ring gantry.  Anatomical scans were acquired at 80 kVp and 
110 mA over a 14 cm transaxial and 5.7 cm longitudinal field of view during an 8-second 
acquisition; as functional information was not being collected, gating scans were not 
performed.  The approximate entrance dose delivered during one scan was 10.1 cGy.  
Images were reconstructed using a cone-beam reconstruction algorithm18 with an 
isotropic voxel spacing of 150 #m.19 
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3.2.3 Image Analysis 
Image analysis was 
performed using 
MicroView (v ABA 2.2, 
GE Healthcare, London, 
ON, Canada).  All images 
were first rescaled into 
Hounsfield units (HU), by 
using water and air 
calibrators.  Regions of 
interest (ROI) 0.45 mm x 
0.45 mm x 0.15 mm in size 
were chosen to correctly 
measure the organs of 
interest without intersecting 
other tissues or vasculature; 
they were generated in the 
left ventricle (LV) to 
measure blood-pool 
contrast, as well as in the liver, spleen, myocardium, renal cortex, bladder, and brown 
adipose tissue (BAT), located suprascapularly (Fig. 3.1).  In each tissue of interest, the 
ROI was drawn in 3 different coronal slices, with care taken to avoid the major arteries, 
as that would artificially increase the CT number.  The CT number from each of the 3 
ROIs was averaged together, to obtain a mean CT number for each tissue at each time 
point, for each mouse. 
For each strain, enhancement time curves were generated for all tissues by 
averaging the CT values measured at each time point for all mice within the respective 
groups.  
 
Figure 3.1:  Coronal (a, b) and sagittal (c) images of a 
C57BL/6 mouse 30 minutes post-administration of the 
contrast agent, displaying the ROIs drawn in each tissue 
to determine enhancement.  LV, left ventricle; My, 
myocardium; L, liver; B, bladder; K, kidney (renal 
cortex); S, spleen; BAT, brown adipose tissue. 
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3.2.4 Statistical Analysis 
All values are reported as mean ± SD for continous variables.  Analysis was 
performed using Prism 4 (GraphPad Software, Inc., San Diego, CA). Repeated measures 
2-way ANOVA and Bonfferoni post-tests were performed for each tissue type to measure 
enhancement differences between strains over time.  Results were considered statistically 
significant at p<0.05. 
 
3.3 Results 
Scans were successfully acquired and images reconstructed for each animal at 
each time point.  The contrast agent was well tolerated by the mice in this study, with 
only minor lethargy witnessed in between scans – possibly a consequence of the animal 
metabolizing the contrast agent, or perhaps due to the repeated anesthesia sessions.   
The enhancement values measured for each mouse were averaged together by 
strain, and the resulting enhancement-time curves were plotted by tissue type in Figure 
3.2.  The LV showed immediate enhancement upon injection, with the peak enhancement 
occurring at the 5-minute scan and measuring 687 HU ± 86 HU above the precontrast 
value in the C57BL/6 group and 666 HU ± 53 HU above the precontrast value in the 
BALB/c group.  The high contrast in the blood-pool dropped rapidly in both strains 
during the first 2 hours and reached baseline values by the 8-hour time point. 
The myocardium showed a continual increase in contrast over the first 2 hours, 
peaking in enhancement at the 4-hour time point (278 ± 13 HU and 272 ± 27 HU above 
precontrast in the C57BL/6 and BALB/c groups, respectively).  Figure 3.3 visually 
illustrates the time-course of eXIA 160 enhancement in the LV and myocardium; note 
that by one hour post contrast agent administration, the myocardium was sufficiently 
enhanced to inhibit accurate LV segmentation, which relies on adequate differentiation 
between the blood in the LV chamber and the myocardium.  
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Figure 3.2:  Enhancement-time curves of the tissues measured.  Black line represents 
C57BL/6 group, red line represents BALB/c group.  P-values listed on each plot 
represent the results of a repeated-measures 2-way ANOVA comparing the strains.  
*represents significant differences. 
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As LV segmentation is required to measure cardiac function, it was therefore 
important to determine the optimal timeframe during which cardiac-related scans should 
be acquired.  This was accomplished by plotting the LV and myocardium enhancement-
time curves together (Fig. 3.4a).  The times post injection corresponding to the highest 
contrast between LV blood and myocardium can be determined from Fig. 3.4b, which is 
a plot of the difference between the myocardial and LV values over time. 
 
 
 
 
 
 
 
Figure 3.3:  Coronal slices from 3D images of the same C57BL/6 mouse scanned at 
different time points.  Note that at the one-hour time point, the myocardial 
enhancement is beginning to obscure the LV chamber, and that by the four-hour time 
point, the myocardial enhancement is sufficient to enable LV wall segmentation. 
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eXIA 160 also 
provided enhancement in 
the liver and spleen (Fig. 
3.5).  In both strains, peak 
liver enhancement occurred 
2 hours post-injection (299 
HU ± 26 HU and 365 HU ± 
23 HU above the 
precontrast value for the 
C57BL/6 and BALB/c 
groups, respectively) and 
dropped close to baseline 
values by 24 hours.  
Likewise, the spleen 
displayed peak 
enhancement early in the 
study (45 minutes for 
C57BL/6 group and 1 hour 
for BALB/c group) with 
values of 802 HU ± 165 HU and 714 HU ± 60 HU, respectively; precontrast levels were 
reached within 24 hours. 
The renal cortex of the kidneys showed average enhancement immediately 
following injection of the contrast agent (Fig. 3.5), and maintained a steady contrast (an 
enhancement over baseline of approximately 130 HU) for the first several hours, with a 
slow decline towards precontrast values by 24 hours (Fig. 3.2).  Bladder enhancement 
was consistent with the production of urine as the contrast agent was filtered through the 
kidneys (Fig. 3.2). 
Another unique elimination pathway was reflected in the enhancement of the 
brown adipose tissue (BAT), which was most noticeable in the suprascapular BAT 
deposit (Fig. 3.5).  Enhancement values peaked at 12 hours, with values of 639 ± 105 HU 
 
Figure 3.4:  (a) Enhancement-time curves for the left 
ventricle (LV) and myocardium for the C57BL6 group. 
(b) Value of the difference between LV blood pool and 
myocardium for both strains studied. 
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for the C57BL/6 group and 497 ± 87 HU for the BALB/c group; contrast remained strong 
in this tissue at 48 hours (270 HU above precontrast values). 
 
A repeated-measures 2-way ANOVA performed on each tissue type indicated 
there were no significant differences between the C57BL/6 and the BALB/c groups, with 
the exception of the liver and BAT, which showed statistically significant differences 
(P < 0.0001 for liver and P < 0.01 for BAT) between the strains. 
 
3.4 Discussion 
Enhancement of over 650 HU, over precontrast values, was measured in the blood 
pool of all mice at 5 minutes following the injection of only 0.1ml of eXIA 160 (in a 20 g 
mouse).  To achieve similar blood-pool enhancement with Fenestra VC, injection 
volumes of 0.4 ml (per 20 g) were required.5  This difference in enhancement is 
consistent with the difference in Iodine loading of the two agents – eXIA 160, contains 
3.2 times more iodine per mL than Fenestra VC.  The present study also demonstrates 
 
Figure 3.5:  Sagittal slices from 3D images of the same C57BL/6 mouse scanned at 
different time points.  The sagittal view was chosen to display a wider range of 
measured tissues.  LV, left ventricle; My, myocardium; L, liver; S, spleen; K, kidney; 
BAT, brown adipose tissue. 
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that eXIA 160 is eliminated from the blood-pool at a faster rate than previously reported 
for Fenestra VC: rather than maintaining a relatively stable enhancement for several 
hours post-injection (half-life of approximately 8 hr),5,20 eXIA 160 enhancement dropped 
40% within the first hour (Fig. 3.2).  However, enhancement values remained above 500 
HU during the first 30 minutes post-injection, thereby providing excellent contrast for a 
period of time sufficient to perform several prospectively gated cardiac micro-CT scans. 
A unique – and unexpected – quality of eXIA 160 was the contrast uptake into the 
myocardium, which may represent one of the ways in which the contrast agent is 
metabolized in the mouse.  Enhancement began immediately following injection of the 
contrast agent, and continued to increase until peak enhancement occurred at 4 hours 
post-administration for both the C57BL/6 (278 HU) and the BALB/c groups (272 HU).  
The increasing enhancement of the myocardium during the first hour did decrease the 
length of time during which scans measuring cardiac function could be acquired, as 
sufficient difference between the LV blood-pool and the myocardium is required for 
proper segmentation of the LV (Fig. 3.3).  In fact, Fig 3.4 demonstrates that between 1 
and 2 hrs post-injection contrast between the blood-pool and myocardium reverses, 
implying that at around 1.75 hr, the contrast is equal to zero.  Therefore, the optimal 
timeframe for acquiring cardiac functional scans is within the first 30 minutes post-
injection (Fig. 3.4); during this time the contrast between the blood and myocardium 
remained above 360 HU.   
Although myocardial enhancement limits the time during which cardiac 
functional studies can be optimally performed, it also offers a number of possibilities for 
further study: for example, an accurate measurement of myocardial mass that is not 
dependent on manual tracing but rather on automatic segmentation; and the ability to 
study wall motion and wall function, normally not feasible with micro-CT, given the low 
soft tissue contrast inherent in the imaging technique.  Therefore, eXIA 160 may be 
advantageously used as a dual-phase cardiac contrast agent, capable of providing contrast 
for LV function soon after injection, then enhancing the myocardium for wall motion 
studies at a further time-point in the experiment in the same animal.  Referring again to 
Fig. 3.4, the cardiac function scans could optimally be acquired in the first 30 minutes 
post-injection, and the LV wall-related scans acquired between 4 to 8 hours post-
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injection.  Additionally, the potential use of eXIA 160 to evaluate myocardial wall 
structure and function may also prove to be of use in multi-modality imaging studies; an 
injection of a molecular imaging contrast agent, in addition to eXIA 160, would enable 
monitoring of metabolic activity during SPECT/CT and PET/CT experiments.21 
In addition to providing blood-pool contrast for an extended period of time, eXIA 
160 also enhanced a number of other tissues as it was eliminated from the body.  The 
liver and spleen appear to be major clearance pathways; this is similar to Fenestra VC, 
which was developed specifically to be eliminated by the hepatobiliary system.4  
However, given that the spleen has a central role in the reticuloendothelial system (RES), 
it is likely that Fenestra is also eliminated at least partly by the RES.  The similar 
enhancement pattern of eXIA 160 therefore suggests that the contrast agent was 
eliminated by one or both of these systems.  Peak enhancement of eXIA 160 in the spleen 
occurred 45-60 minutes post-injection and in the liver 2 hours post-injection, in contrast 
to Fenestra VC, which has a peak enhancement at 24 hours post-injection in both 
organs.20  This suggests that, although eXIA 160 may have a similar elimination pathway 
to Fenestra VC, it is metabolized more quickly.  In addition, eXIA 160 administration 
produced kidney and bladder enhancement; kidney enhancement began in both strains 
immediately following injection, signifying the contrast agent was not metabolized but 
rather filtered unaltered through the glomeruli and eliminated in the urine.  Unlike the 
enhancement time-course of Fenestra VC, which does not lead to kidney/bladder 
enhancement, eXIA 160 appears to partly mimic the main elimination pathway of clinical 
contrast agents.1  The multiple elimination pathways observed in this study are consistent 
with, and likely a result of, the poly-disperse nature of the eXIA contrast agent.  
Enhancement of the BAT was witnessed, which peaked at 12 hours for both 
strains, and measured 639 HU (C57BL/6) and 497 HU (BALB/c) above baseline.  The 
mechanism of this uptake is as unclear, but contrast was still present at the 48-hour time-
point, indicating eXIA 160 is metabolized slowly in this tissue.  BAT is responsible for 
non-shivering thermogenesis, and low body temperature has been shown to increase 
uptake of glucose-based tracers used in nuclear imaging.22  Although eXIA 160 would 
not enter the BAT via glucose receptors, it is possible that the body temperature of the 
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mouse may likewise have an effect on contrast agent uptake.  Further studies are required 
to explore this effect. 
Earlier work by Willekens et al. also reported enhancement curves for eXIA 160 
in the liver and spleen;13 however, the values reported were dramatically lower than 
observed in this study.  Willekens et al. presented their results as “percent contrast,” 
rather than in HU, making direct comparison difficult.  However, converting the data in 
our study using the equation provided by Willekens (difference between pixel value at a 
given time point and the unenhanced pixel value of the same region, normalized by the 
unenhanced pixel value and expressed as a percentage) the enhancement values we 
achieved ranged from 181% in the renal cortex to 1135% in the spleen.  The largest value 
reported by Willekens was 38% in the spleen, which was particularly surprising given 
that a 50 kVp x-ray spectrum was used; this should have generated images with a larger 
“percent contrast” than those generated with the 80 kVp spectrum used in our study.  
Willekens’ study also measured enhancement-time curves for Fenestra VC that were 
much lower than the enhancement values reported previously.20  A potential explanation 
may lie in the challenge of performing tail vein injections: it is possible that in Willekens’ 
study, a portion of the contrast agent accumulated in the tail space rather than entering the 
vein, artificially lowering the observed enhancement values.  Another difference between 
the two studies is the more rapid decrease in blood pool enhancement observed by 
Willekens’ study, which can also be attributed to a smaller amount of contrast entering 
the blood stream during injection.  
The present study is the first to compare the uptake and elimination of eXIA 
contrast in two different strains of mice.  Both the C57BL/6 and BALB/C mice studied 
displayed excellent contrast in the vasculature and very similar elimination times, 
indicating that cardiac functional measurements can be performed using micro-CT on 
either strain without the need to adjust the protocol or times reported in this study.  There 
did appear to be some difference in the way the strains metabolized the contrast agent, 
evidenced by the significantly different enhancement-time curves for liver and BAT; 
when the liver and BAT measurements were compared, the C57Bl/6 group showed lower 
liver values, but higher BAT values, than the BALB/c group.  Although it is not clear 
why this disparity between strains is occurring, the significant differences seen in BAT 
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enhancement suggest there may be variations in the way the two strains regulate body 
temperature.  It is interesting to note that for both strains the enhancement curves (Fig. 
3.2) for all tissues (other than bladder and BAT) had very tight standard deviations of the 
mean values for the 6 mice in each group (on the order of 20 HU, except for the blood 
pool during the first hour, where the SD was approximately 60 HU).  This result suggests 
that all 20-24 g mice of the two strains studied metabolize the contrast agent with similar 
a time course.  The larger SDs observed in the bladder are related to the continuous 
elimination of urine; since the contrast agent is denser and settles during the scans, the 
measurement is highly sensitive to the position of the ROI.  The high standard deviation 
of the values obtained in the BAT can be explained by possible variations in body 
temperature, or to ROI position sensitivity (BAT is highly vascularized). 
eXIA 160 was well-tolerated by the mice in this study.  All mice returned to 
normal behavior soon after being removed from anesthesia; except for a slight lethargy 
around the 4-hour time point, all mice recovered all normal activity within the first 8 
hours.  However, in other experiments (unpublished) performed on larger mice (~35-40 
g), the same dose (5 #L/g body weight) had adverse effects, with a mortality rate of 
approximately 50% occurring between 24 and 48 hours. Post mortems performed on the 
affected animals showed necrotic areas in the kidneys and liver, organs responsible for 
metabolizing and eliminating the contrast agent.  This may indicate that higher doses 
cause liver and/or renal toxicity, although the cause of death was ultimately determined 
inconclusive.  Mortality following higher doses was also seen in previously reported data 
(Willekens et al.)23, where administration of twice the dose (10 #L/g body weight) to 
mice ~25 g in size resulted in a 100% mortality rate within 48 hours.  These combined 
results suggest there is an upper tolerance limit on the total amount of eXIA 160 a mouse 
can adequately process and eliminate, and that a dosage based on body weight is not 
appropriate for larger animals.  We suggest that for mice larger than 30 g, no more than 
0.15 mL eXIA 160 be administered, in order to prevent adverse effects. 
 
3.4.1 Conclusion 
eXIA 160 is a blood-pool contrast agent with a high iodine concentration, making 
it possible to administer a low volume of contrast to the mice, and reduce potential 
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negative hemodynamic effects.  Excellent, strain independent, contrast was observed 
between myocardium and blood (ranging between 560 and 330 HU) during the first 30 
minutes post contrast administration.  Myocardial enhancement peaked at 4 hours 
(contrast between blood and myocardium of approximately 200 HU), enabling dual-
phase cardiac imaging, where both function and myocardial mass and motion can be 
studied in the same animal. 
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4 X-ray dose delivered during a longitudinal micro-CT 
study has no adverse effects on cardiac and 
pulmonary tissue in C57BL/6 mice 
The contents of this chapter are in preparation to be submitted as a paper with 
the author list Sarah A. Detombe, Joy Dunmore-Buyze, Ivailo E. Petrov, and Maria 
Drangova. 
 
4.1 Introduction 
Mouse models have become a critical element of preclinical research; at least 
80% of the genes in the mouse genome represent an analogous gene in the human 
genome, and diseases can often be modeled that behave in ways similar to diseases in 
humans.1,2  Specifically, mouse models have become popular for modeling 
cardiovascular disease.  As a result, technological advances have led to the development 
of imaging techniques capable of visualizing small animal cardiovascular systems with 
sufficient detail.  In particular, micro-computed tomography (micro-CT) offers numerous 
advantages for small animal imaging: rapid scan times ranging from seconds to minutes, 
and the acquisition of high-resolution images with isotropic voxels enables evaluation of 
the mouse with minimal impact on the animal’s physiology.3  Additionally, dynamic 
acquisition of images using gating techniques enables functional measurements of the 
cardiovascular system in free breathing mice, with scans that are both rapid and 
reproducible.4-7  As a result, micro-CT can be particularly useful for detecting the onset 
of, and monitoring the progression of, cardiac diseases, and phenotype characterization 
can be performed with the addition of a contrast agent, facilitating measurement of 
changes in heart size and myocardial structure.8 
The non-invasive quality of micro-CT enables its use in longitudinal studies,6 
where the same animal can be scanned multiple times over the course of the study.  
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Disease progression can therefore be tracked in an individual animal, allowing it to act as 
its own control, and potentially reducing the number of animals required to produce 
statistical significance in a study. 
One of the main drawbacks of micro-CT often stated is a concern over the x-ray 
dose delivered during the scans.  A typical ungated micro-CT scan delivers a dose of 
10 cGy9 which, although much smaller than the LD50 of the mouse,10 is larger than the 
dose delivered during a clinical cardiac CT (2-5 cGy).11  This is particularly relevant in 
longitudinal studies, where more than one scan is performed per animal.  Additionally, 
the cardiac-gated scans required for cardiovascular studies deliver a larger dose.7 
Radiation damage has been shown to cause cardiac hypertrophy and decrease left 
ventricular systolic function in the form of a lowered ejection fraction,12 although a fairly 
high x-ray dose (16 Gy) is required to cause this damage.  Pulmonary tissue is more 
sensitive to radiation-induced damage than myocardial tissue, and in a cardiovascular 
study the lungs will be exposed to the same amount of radiation as the heart.  As the 
lungs are more likely to display evidence of radiation exposure before the heart, it would 
be beneficial to evaluate the pulmonary tissue, in addition to the myocardial tissue, for 
adverse effects related to the delivered dose of a cardiac micro-CT study.   
There have been a number of studies looking at the effect of dose on pulmonary 
tissue in mice;13, 14 however, they have focused mainly on investigating radiotherapy 
doses of 10-20 Gy delivered in a single session at the beginning of the study.  
Additionally, evaluation of dose effects typically does not begin for 8-12 weeks 
following exposure.  This creates some difficulties in trying to apply the results to a 
typical micro-CT study, where the doses are smaller, often by a factor of 100, delivered 
multiple times over a period of weeks, and often less than eight weeks in length. 
The objective of this study was to reproduce a longitudinal cardiac micro-CT 
study and evaluate the effects of dose on pulmonary and myocardial tissue.  We scanned 
C57BL/6 mice multiple times per week for six weeks, and evaluated micro-CT images 
for any anatomic or functional changes to the lungs and heart, and performed histology to 
determine if any effects were seen at a cellular level. 
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4.2 Methods 
4.2.1 Animal Groups and Delivered Dose  
Twenty C57BL/6 male mice (24 ± 1 g) were split into two groups: the first was 
the Irradiated Group, which was scanned weekly for six weeks; each weekly session was 
comprised of three scans (thereby providing three times the dose of a typical micro-CT 
study).  The second group was a Control Group, which was not scanned until week six.  
In an effort to assess both the pulmonary and cardiac systems, in the final week both 
groups were first scanned using respiratory gating to evaluate the lungs; a contrast agent 
(5 #l/g body weight eXIA 160 (Binitio Biomedical Inc, Ottawa, Canada) was then 
administered via the tail vein and a cardiac-gated scan was acquired to evaluate the heart. 
Each scan delivered an entrance dose of 0.28 Gy;7 as a result, the Irradiated Group 
received a weekly dose of 0.84 Gy, and a total entrance dose of 5.04 Gy by the end of the 
study.  All studies performed were approved by the Animal Use Subcommittee of the 
University Council on Animal Care at The University of Western Ontario. 
 
4.2.2 Scan Protocol 
Prior to scanning, mice were anesthetized with 1.5% isoflurane in O2, and placed 
prone on the micro-CT bed.  When required for respiratory gating, a pneumatic pillow 
was placed beneath the diaphragm to measure breathing signals; likewise, when required 
for cardiac gating, neonatal electrodes (2269T, 3M Health Care, St. Paul, MN) were 
affixed to the paws to measure ECG.  These physiological signals were recorded using a 
monitoring and triggering system (BioVet; m2m Imaging Corp., Newark, NJ).  
Temperature was maintained between 36°C and 37°C during the entire experiment.   
Weekly scans were performed using a volumetric cone-beam micro-CT scanner 
(Locus Ultra, General Electric Healthcare, London, ON, Canada), equipped with a flat-
panel detector mounted on a slip-ring gantry, enabling continuous acquisition of x-ray 
projections.  Projection images were acquired at 80 kVp and 50 mA over 10 rotations (5 
seconds per rotation, 416 projection images per rotation at a rate of 12 
milliseconds/projection) for a total acquisition time of 50 seconds per scan. 
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4.2.3 Retrospectively-gated reconstruction 
All gated reconstructions performed in this study were done using the technique 
described by Armitage et al.15 and were reconstructed with 150 #m isotropic voxels.9 
Respiratory Gating: Respiratory-gated reconstructions were performed on week 
six scans for mice in both groups.  Projection images were sorted based on the phase of 
the respiratory cycle during which they were acquired; images at both peak-inspiration 
and end-expiration phases were reconstructed.  The average window sizes of the two 
phases were 63 ms and 140 ms, respectively. 
Cardiac Gating: Cardiac-gated reconstructions were performed on week six scans 
acquired following the injection of the contrast agent.  Projection images were sorted 
based on the phase within the cardiac cycle during which they were acquired, enabling 
subsequent reconstruction of 3D images at 12-ms intervals.  For this study, between 9 and 
12 3D images were reconstructed per cardiac cycle, depending on the heart rate.   
 
4.2.4 Image analysis 
Image analysis was performed using MicroView software (version ABA 2.2, 
General Electric Healthcare, London, ON, Canada).  Images were initially converted to 
Hounsfield units (HU) using water and air samples in the reconstructed image as a 
reference. 
Respiratory analysis: To calculate lung volume, an upper threshold was first 
identified for segmenting the lung from the surrounding thoracic tissue; this was 
performed by generating a region of interest (ROI) that contained 50% lung tissue, and 
50% surrounding tissue.  The threshold was then automatically determined16 as -220 HU.  
A lower threshold was chosen as -750 HU, which effectively segmented the lung 
parenchyma from the major airways (trachea, bronchi).  An ROI was generated around 
both lungs, and a segmented region-growing algorithm segmented the lung tissue using 
the upper and lower thresholds previously determined.  Thresholds were the same for 
both inspiration and expiration.  The volume was determined for both inspiration and 
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expiration phases; the density for both phases was determined by finding the mean CT 
number of the segmented lung tissue.   
Cardiac analysis: To calculate LV volume, a threshold level that separated the 
myocardium from the blood pool was identified automatically;16 this was done separately 
for each scan, as contrast level in the blood changed over the course of the study.  As 
described in prior studies,6, 7 automatic segmentation of the LV chamber from the 
myocardium was achieved using a region-growing approach.  LV volume was calculated 
for each image throughout the cardiac cycle, and the minimum and maximum were used 
as end-systolic volume (ESV) and end-diastolic volume (EDV), respectively.  Knowledge 
of the ESV and EDV enabled ejection fraction (EF) to be calculated. 
 
4.2.5 Histology 
Following the final scan on week six, the mice were euthanized and the lungs and 
heart were extracted.  Lungs were inflated with 10% formalin, and both the lungs and 
heart were fixed in the formalin solution.  The tissue was then embedded in paraffin and 
sliced 4 #m thick.  Slices were stained with hematoxylin and eosin and evaluated for 
evidence of dose-related damage (i.e. early inflammation in the form of inflammatory 
cells and edema). 
 
4.2.6 Statistical analysis 
Data are presented as mean ± SD for continuous variables; all analysis was 
performed using Prism 4 (GraphPad Software, Inc., San Diego, CA).  Unpaired t-tests 
were used to evaluate changes in lung volume and lung density between the Irradiated 
Group and the Control Group, for both the inspiration and expiration phases.  Unpaired t-
tests were also used to assess differences in cardiac function between the two groups; 
systolic and diastolic volume, and EF were evaluated.  Results were considered 
statistically significant at p<0.05. 
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4.3 Results 
Scans from all animals acquired in the final week were successfully reconstructed 
and analyzed.  Overall, the x-ray dose delivered during the longitudinal study had no 
significant effect on mouse pulmonary and cardiac tissue. 
Qualitatively, the lungs displayed no visual differences between the two groups 
(Fig. 4.1).  This was reflected quantitatively both in lung volume (Fig. 4.2) and lung 
density (Fig. 4.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Coronal slice of micro-CT image from an irradiated mouse (a) 
and a control mouse (b) during inspiration.  Note the apparent lack of 
density and volume changes in (a) compared to (b). 
 
Figure 4.2: A comparison of lung volume between the Irradiated and the 
Control Group, for both expiration and inspiration phases.  No significant 
differences were measured between groups for either phase. 
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T-tests comparing lung volume between the Irradiated and Control groups 
indicated no significant differences in either expiration (p=0.3492) or inspiration 
(p=0.4841) phases.  Similarly, t-tests comparing lung density showed no significant 
differences in either expiration (p=0.3566) or inspiration (p=0.4432). 
More importantly, histological samples of pulmonary tissue showed no early 
damage in the Irradiated Group as compared to the Control Group (Fig. 4.4).  This early 
damage would show up in the form of inflammatory cells filling up the air spaces, but no 
evidence of this is present. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: A comparison of lung density between the Irradiated and the 
Control Group, for both expiration and inspiration phases.  Differences 
between groups was not significant for either phase. 
 
Figure 4.4: Histological slides of pulmonary tissue taken from an 
irradiated mouse (a) and a control mouse (b).  Magnification at x100.  No 
evidence of early inflammation is present in the irradiated mouse, which 
would be identified by the occurrence of inflammatory cells and edema 
within the alveoli. 
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Cardiac function was also evaluated; qualitatively, no changes to the myocardium 
are evident (Fig. 4.5), which is also reflected quantitatively in the evaluation of LV 
volume and ejection fraction.  No significant differences between the Irradiated and 
Control groups were witnessed in LV systolic (p=0.1953) and diastolic (p=0.0807) 
volumes (Fig. 4.6), nor were there any changes in ejection fraction (p=0.9263) (Fig. 4.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Coronal slices of a micro-CT image of an irradiated mouse (a) and 
a control mouse (b), displaying the heart in diastole.  Note the similarity in LV 
volume and myocardial thickness between the two mice, indicating that no 
adverse dose effects have occurred. 
 
Figure 4.6: A comparison of systolic and diastolic LV volumes between the Irradiated 
Group and the Control Group.  Differences between the groups was not significant for 
either phase. 
71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Similar to the evaluation of pulmonary tissue, histological samples of the 
myocardium were evaluated, and no signs of early dose-related damage were present 
(Fig. 4.8). 
 
 
 
 
 
Figure 4.7: A comparison of cardiac function 
between the Irradiated Group and the Control Group, 
measured using ejection fraction.  No significant 
differences in function were measured between 
groups. 
 
Figure 4.8: Histological slides of myocardial tissue taken from an 
irradiated mouse (a) and a control mouse (b).  Magnification at x100.  No 
evidence of fibrotic tissue is present in the irradiated mouse, indicating that 
x-ray dose had no adverse effects. 
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4.4 Discussion 
The goal of this study was to determine the effects, if any, of x-ray dose delivered 
during a typical longitudinal cardiac micro-CT study on the myocardial and pulmonary 
tissue in C57BL/6 mice.  Both pulmonary and cardiac tissue were evaluated because, 
during a cardiac scan, the field of view is centered on the heart and the lungs are 
inevitably irradiated, even with a narrow FOV.  This is significant because pulmonary 
tissue has a higher radiosensitivity than myocardial tissue; any early indications of 
radiation-induced damage will present in the lungs. 
Radiation-induced lung damage is generally split into two phases: an early acute 
inflammatory phase, often called radiation pneumonitis, and a later chronic fibrosis 
phase.17  As fibrosis typically develops 4-6 months following radiation exposure, an early 
inflammatory reaction would be the most likely to occur if a micro-CT study caused 
damage.  Signs of an inflammatory reaction are marked by an increase in inflammatory 
cells and edema within the air spaces of pulmonary tissue, which can be seen 
histologically.  On a micro-CT image, these changes would result in a decrease in lung 
volume, and an increase in lung density. 
Referring to Figs. 4.2 and 4.3, there were no significant changes to either lung 
volume or lung density in the Irradiated Group compared to the Control Group, indicating 
that a cumulative entrance dose of 5.04 Gy caused no significant damage apparent at an 
anatomic level.  More importantly, histology of the pulmonary tissue (Fig. 4.4) showed 
no early signs of inflammation at a cellular level – there were no inflammatory cells 
accumulating in the air spaces, no edema was present, and no vascular dilation of the 
capillaries surrounding the alveoli.  This is strong evidence that the dose delivered during 
a longitudinal micro-CT study does not have an adverse effect on the mouse. 
The results presented are consistent with other studies that have evaluated 
radiation damage to the lungs in mice.  In general, a dose threshold of 12 Gy needs to be 
exceeded in order for radiation pneumonitis to occur in mouse models.18-21  This is 
confirmed more recently by Jackson et al.,13 which showed that C57BL/6 mice irradiated 
with a single 15 Gy dose delivered to the thorax displayed no changes to lung volume or 
lung density at 16 weeks following exposure, and that changes at a cellular level were 
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detectable histologically at 28-32 weeks.  Interestingly, Johnston et al. has recently 
indicated that doses of 10 Gy delivered full-body may have an effect beyond 12 
months;14 however, these effects, detectable histologically as the onset of fibrosis, with 
increased levels of collagen in areas of tissue remodeling and inflammation, did not result 
in changes to lung function, as measured by changes in breathing rate. 
The myocardial tissue was also evaluated for evidence of dose effects.  The most 
significant type of radiation-induced heart disease is myocardium damage,22, 23 which 
would result in evidence of degenerative morphological changes of cardiomyopathy such 
as myocyte degeneration/necrosis, increase in the amount of interstitial fibrous 
connective tissue, mineralization, and/or presence of mononuclear cells in histological 
analysis.24  On a micro-CT image, this would present as cardiac hypertrophy (a 
thickening of the LV wall and an enlargement of the heart), with a decrease in ejection 
fraction. 
As Figures 4.6 and 4.7 indicate, there were no significant changes to either the LV 
volume, or the ejection fraction in the Irradiated Group, although the p-value of the 
diastolic volume (0.0807) is very close to significance, suggesting that there may be some 
difference between the Control and the Irradiated Groups.  However, given that there was 
no evidence of radiation damage present in the pulmonary tissue, it is likely that the 
potential differences in volume between groups are due to biological variability, rather 
than dose effects.  This is further supported by Figure 4.5, which shows no changes to 
wall thickness, and Figure 4.8, which confirms no evidence of myocyte degeneration, or 
presence of inflammatory cells occurring interstitially.  Although not unexpected, these 
results are consistent with other studies evaluating radiation damage to the heart, which in 
general show that larger doses and a longer period of time are required to cause 
measurable damage.  For example, Monceau et al. delivered a dose of 16 Gy to the 
thorax of C57Bl/6 mice and witnessed radiation-induced cardiac hypertrophy 15 weeks 
following irradiation;12 however a significant decrease in ejection fraction did not occur 
until 30 weeks.  Qian et al.25 evaluated short-term effects of 7 Gy delivered to the heart, 
and found that a mild myocyte degeneration was not witnessed until 100 days following 
treatment.  A study which may have more relevance to micro-CT experiments was 
described by Baker et al.:26 performed in rats, they found that 10 Gy delivered full-body 
74 
 
had the potential for indirectly contributing to heart disease development, compared to 10 
Gy delivered to the thorax alone, which had no significant effect on the myocardium.  It 
was proposed that full-body exposure had effects on non-thoracic organs that contributed 
to coronary sclerosis and ventricular dysfunction through changes in blood lipid profiles.  
However, it is important to note that these effects were not witnessed until 120 days 
following exposure, and that the animals were irradiated in a single dose much larger 
than would be delivered during a longitudinal micro-CT study.  
The results presented in this study have relevance beyond the applicability to 
other cardiac micro-CT experiments.  A scan protocol for retrospective gating was used, 
which means that these results can be applied to any micro-CT study that employs 
prosepective gating, or ungated scans, which deliver a lower dose than presented here.  
Additionally, the dose was purposely tripled beyond a typical dose, widening the variety 
of studies to which these results can be applied.  Finally, studies in which micro-CT is not 
used longitudinally can also benefit from the results presented, which indicate that the 
small dose delivered will have no adverse effects on the health of the animal. 
The C57BL/6 mouse strain was used, as it is one of the most common strains used 
in biomedical applications.13  However, variations in radiation-induced damage between 
patients in a clinical setting indicate that the damage has a genetic component.  This is 
further supported by studies that present differences in radiation-induced lung damage 
between mouse strains.13, 20  But from these studies we can also infer that, given the lower 
doses (below 12 Gy) of a longitudinal micro-CT study, and the short time frame involved 
(less than 8 weeks), it is highly unlikely that strain-related differences in radiation effects 
would occur. 
Not addressed in this study is the possibility that cardiac sensitivity to stress may 
be affected by dose, ultimately resulting in a change in function.  A future study may 
address this by incorporating a cardiac stress test (using, for example, a dobutamine 
injection); however, given that the x-ray dose presented here had no apparent effects on 
the more radiosensitive pulmonary tissue, it is unlikely that the dose delivered during the 
relatively short time-frame of a micro-CT study would result in an abnormal stress test. 
Also not covered by this study is the effect of dose delivered during a micro-CT 
experiment on cancer mouse models.  Longitudinal evaluation of tumor growth, 
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regression, or metastasis is useful for evaluating new therapeutic approaches.27, 28  
Although the dose delivered during micro-CT scans has no negative effect on the health 
of the animal, it is uncertain how the radiation dose may influence the fast-growing 
tumor-cells, potentially confounding the investigation of treatment therapies.  Future 
studies should address this area of research. 
 
4.4.1 Conclusion 
The x-ray dose delivered during a longitudinal cardiac micro-CT study had no 
significant effects on the pulmonary and myocardial tissue in mice.  Due to the artificially 
high dose delivered during this study, the results presented can be applied to a wide 
variety of micro-CT experiments; therefore the benefits of using micro-CT, including 
rapid scan times that produce high-resolution isotropic images, can be safely taken 
advantage of without concern that the dose delivered will have an adverse effect on the 
animal or the study. 
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5 Rapid micro-computed tomography suggests cardiac 
enlargement occurs during conductance catheter 
measurements in mice 
The content of this chapter has been adapted from “Rapid micro-computed 
tomography suggests cardiac enlargement during conductance catheter measurements in 
mice” by Sarah A. Detombe, Fuli Xiang, Joy Dunmore-Buyze, James A. White, Qingping 
Feng, and Maria Drangova.  It is currently in press with the Journal of Applied 
Physiology. 
 
5.1 Introduction 
Genetically modified mice, such as transgenic and gene-targeted models, are used 
in cardiovascular research as a way to determine the molecular basis for cardiac 
dysfunction.  The small size and rapid heart rate have necessitated the development of 
tools specifically designed to track and measure cardiac function on a small scale.  One 
widely used technique involves the measurement of real-time pressure and volume 
changes in the left ventricle (LV) using a micro pressure conductance catheter (CC) 
inserted into the heart.  Baan et al. first presented a method for relating conductance to 
volume1 using the equation V = "L2 (G - Gp)/! where " is the resistivity constant, L is the 
length between the electrodes, ! is Baan’s constant, G is the total conductance measured, 
and Gp is the parallel conductance of the surrounding tissue.  This technique was first 
used in large animals2,3 and humans,4 but with the development of miniaturized 
micromanometers, it was translated for use in mice.5-8  The CC technique allows 
assessment of LV function by load-independent indexes (e.g. the slope of the end-systolic 
pressure-volume (PV) relation),5,9 which are more sensitive to small changes in 
dysfunction than load-dependent measurements such as ejection fraction.10  This 
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increased sensitivity is especially important when detecting changes in contractility early 
in disease progression. 
Accurate PV relationships require an accurate absolute volume, but a number of 
recent studies comparing CC volumes with those derived from imaging methods have 
shown that catheter-based measurements tend to underestimate ventricular volumes in 
both healthy and diseased mice.  These studies have compared CC volumes to volumes 
obtained from magnetic resonance imaging11-13 or echocardiography;14 however, in most 
cases the measurements were not performed simultaneously, with imaging occurring one 
to two days prior to the CC experiments.  The differences between CC-derived volumes 
and imaging may be explained, in part, by differences in respiratory support (free 
breathing vs. intubated and ventilated)13 or the residual functional depressive effects due 
to repeated anesthesia.13  The most recent study, by Porterfield et al.14 compared CC 
measured volumes to volumes determined from simultaneously acquired 2D 
echocardiographic images (using the prolate ellipse method to estimate volume) and 
reported discrepancies between the imaging and CC volumes that were highly dependent 
on the position of the conductance catheter within the LV.  Retrospective review of the 
data reported by Porterfield also identifies a great variation in LV size between mice (end 
diastolic volumes ranging between 22 and 55 #L), which could be attributed to biological 
variability, but may represent a previously unreported enlargement of the LV during the 
insertion of the conductance catheter. 
The present study takes advantage of a micro-computed tomography (CT) 
technique – retrospectively gated cardiac micro-CT – which produces high-resolution 
three-dimensional (3D) images of the mouse heart over the entire cardiac cycle, in scan 
times of just under one minute.15,16  Using this imaging technique we were able to 
compare simultaneously acquired micro-CT and CC measurements of LV volumes in 
healthy and infarcted mice and to determine changes in LV volume and function 
associated with the insertion of the catheter.  For the first time, these simultaneous 
measurements have been made without the necessity to make any geometrical 
assumptions, often associated with two-dimensional (e.g. 2D echocardiography) or thick-
slice 3D imaging (e.g. MRI). 
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5.2 Methods 
All studies performed were approved by the Animal Use Subcommittee of the 
University Council on Animal Care at The University of Western Ontario. 
 
5.2.1 Experimental Strategy 
Twenty C57BL/6 male mice, weighing 27.5g ± 4.5g, were split into two groups of 
ten mice each.  One group underwent ligation of the left coronary artery 4 weeks prior to 
scanning (MI group); the other group was scanned without prior surgical intervention 
(Normal group).  To determine the effects of catheterization on the mouse heart, each 
mouse was scanned three times using retrospectively gated micro-CT: 1) prior to 
catheterization, 2) with the catheter placed in the LV and acquired simultaneously with 
CC measurements, and 3) upon withdrawal of the catheter from the LV into the carotid 
artery.  The final scan was performed to determine if any effects of the catheter on the LV 
were reversed upon catheter withdrawal.  Details regarding each step of the procedure are 
described below. 
 
5.2.2 Induction of Myocardial Infarction 
Surgery was performed as previously described.17  Briefly, animals were 
anesthetized with an IP injection of ketamine (50 mg/kg) and xylazine (12.5 mg/kg) prior 
to intubation.  Atropine (0.05 mg subcutaneous) was administered prior to surgery to 
decrease airway secretion and post-operative mortality. After establishing mechanical 
ventilation, a left thoracotomy was performed, exposing the LV wall; the left coronary 
artery was ligated by positioning a suture between the pulmonary artery out-flow tract 
and the left atrium.  After surgery, mice were treated with an antibiotic agent 
(oxytetracycline, 200 mg/L) via drinking water for 3 days; an analgesic (0.03 mg/kg 
buprenorphine subcutaneous) was administered to relieve pain.  Mice in this group were 
scanned 4 weeks following ligation. 
 
82 
 
5.2.3 Animal Preparation 
Prior to scanning, mice were anesthetized with 2% isoflurane in O2 and intubated.  
A breathing rate of 90 breaths per minute was maintained throughout imaging and 
hemodynamic studies.  A contrast agent (eXIA 160, Binitio Biomedical Inc, Ottawa, 
Canada), containing 160 mg I/mL, was administered at a dose of 7.5 #L/g body weight.  
The contrast agent was slowly injected via the left jugular vein over a 2-minute period 
approximately 10 minutes prior to the first scan.  Each animal was positioned supine and 
three neonatal electrodes (2269T, 3M Health Care, St. Paul, MN) were placed on the 
animal’s paws to record ECG.  Physiological signals were recorded using a physiological 
monitoring and triggering system (BioVet; m2m Imaging Corp., Newark, NJ).  
Temperature was maintained between 36°C and 37°C during the entire experiment.  Once 
the first scan was completed, the animal was catheterized (see below) and an additional 
7.5 #L/g body weight contrast agent was administered over a 2-minute period prior to the 
remaining two scans. 
 
5.2.4 Catheterization and Hemodynamic Measurements 
Following the initial scan, the mice were catheterized using a micro-pressure 
conductance catheter (Millar Instruments, model SPR-839, 1.4F).  The right carotid 
artery was cannulated and the catheter inserted and advanced into the LV.  Correct 
placement of the catheter was determined solely by the physiologic PV loop in an effort 
to replicate a typical experimental environment (i.e. imaging was not used to provide 
additional guidance); final acceptance of the placement depended on loop appearance.  
The right jugular vein was also cannulated, and a 10-#L bolus of 15% saline was injected 
to measure parallel conductance; this was performed prior to the second scan.  
Hemodynamic data (relative volume units (RVU), pressure, dP/dt) were recorded using a 
Power Lab analog-to-digital converter using Chart 5 software (ADInstruments Inc., 
Colorado Springs, CO).  A trigger signal, indicating the start of image acquisition, was 
also recorded to synchronize the hemodynamic measurements with the CT images; the 
second scan was acquired approximately 7-10 minutes following catheter insertion.  The 
catheter was then withdrawn into the carotid artery (determined solely by hemodynamic 
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feedback) and a third scan was acquired immediately following catheter withdrawal (less 
than 2 minutes).  Following the final scan, blood was collected for volume calibration, 
using cuvettes of a known volume to determine the linear conductance-to-volume 
relationship; the blood was drawn directly from the heart using a syringe flushed with 
heparin.  This was performed separately for each mouse due to possible variability caused 
by the presence of contrast agent in the blood.  All hemodynamic parameters were 
collected and analyzed using PVAN software (Millar Instruments, Houston, TX), using 
the RVU method, which requires only a single measurement of parallel conductance and 
volume calibration using the cuvette method. 
 
5.2.5 Retrospectively Gated Micro-CT 
This method has been previously described, and used to successfully evaluate 
cardiac function in both healthy and MI mice.15,16  Images were acquired using a 
volumetric cone-beam micro-CT scanner (Locus Ultra, General Electric Healthcare, 
London, ON, Canada), equipped with a flat-panel detector mounted on a slip-ring gantry, 
enabling continuous acquisition of x-ray projections.  Projection images were acquired at 
80 kVp and 50 mA.  To enable retrospective gating, projections were acquired over 10 
rotations (5 seconds per rotation, 416 projection images per rotation at a rate of 12 
milliseconds/projection) for a total scan time of 50 seconds.  Using the technique 
described by Armitage et al.,18 the projection images were sorted based on the phase 
within the cardiac cycle during which they were acquired, enabling subsequent 
reconstruction of 3D images at 12-ms intervals.  For this study, between 9 and 12 3D 
images were reconstructed per cardiac cycle, depending on the heart rate.  All images 
were reconstructed with voxel spacing of 150 #m x 150 #m x 150 #m (equivalent to 
3.4 nL volume elements).19  
 
5.2.6 Image Analysis 
Image analysis was performed using MicroView software (version ABA 2.2, 
General Electric Healthcare, London, ON, Canada).  To calculate LV volume, a threshold 
level that separated the myocardium from the blood pool was identified automatically;20 
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this was done separately for each scan, as contrast level in the blood changed over the 
course of the study.  As described in prior studies,15,16 automatic segmentation of the LV 
chamber from the myocardium was achieved using a region-growing approach.  Chamber 
volume was calculated by multiplying the number of voxels defining the LV chamber 
(ranging between 7500 (ESV) and 16000 (EDV) in a healthy mouse) and the voxel 
volume (3.4 nL).  LV volume was calculated for each image throughout the cardiac 
cycle, and the minimum and maximum were used as end-systolic volume (ESV) and end-
diastolic volume (EDV), respectively.  Knowledge of the ESV and EDV enabled stroke 
volume (SV), ejection fraction (EF), and cardiac output (CO) to be calculated. 
 
5.2.7 Statistical Analysis 
Data are presented as mean ± SD for continuous variables; all analysis was 
performed using Prism 4 (GraphPad Software, Inc., San Diego, CA).  Agreements 
between the CT and CC methods were evaluated using Bland-Altman analyses, linear 
regressions, and calculated correlation coefficients.  Paired t-tests were performed to 
compare functional parameters between CT and CC measurements.  Differences between 
the three scans in the Healthy and MI groups were compared using repeated measures 
one-way ANOVA, followed by Tukey post-hoc tests to determine where significant 
differences occurred.  Results were considered statistically significant at p<0.05. 
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5.3 Results 
Successful imaging and hemodynamic studies were completed for all 10 of the 
Normal mice and 7 of MI group: one mouse was not successfully ligated, determined by 
a lack of infarct formation, and two did not survive catheterization.  Verification of 
infarct formation was performed several ways: the hearts were removed and examined 
following blood collection, the infarcts were clearly visible on the micro-CT images as 
thin, distended portions at the apex of the LV, and the ejection fractions calculated from 
the micro-CT images indicated decreased LV function. 
CC volumes were consistently underestimated compared to CT volumes, and the 
underestimation increased in the MI group.  Bland-Altman analyses demonstrate this, 
with biases in the Normal group of -18.4 ± 6.5 #L for ESV and -28.9 ± 13.3 #L for EDV 
(Fig. 5.1), and in the MI group -51.6 ± 31.5 #L for ESV and -71.7 ± 29.5 #L for EDV 
(Fig. 5.2).  Linear regression results (Fig. 5.3) indicated a moderate correlation between 
the CT and CC values in the Normal group, and a low correlation in the MI group.   
 
 
 
 
 
Figure 5.1: Comparison of micro-CT (CT) and conductance catheter (CC) end-
systolic (A) and end-diastolic (B) volumes in Normal mice using Bland-Altman 
analysis.  Bias is represented by the solid line, the limits of agreement (LoA = bias 
± 2SD) are represented by the dotted lines. 
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Table 5.1 lists the averages of all the physiological parameters measured by both 
CT and CC methods, with corresponding p-values as determined by t-test analysis.  
 
 
 
Figure 5.2: Comparison of micro-CT (CT) and conductance catheter (CC) end-
systolic (A) and end-diastolic (B) volumes in MI mice using Bland-Altman 
analysis.  Bias is represented by the solid line, the limits of agreement (LoA = bias 
± 2SD) are represented by the dotted lines. 
 
 
Figure 5.3:  Comparison of micro-CT (CT) and conductance catheter (CC) 
volumes in Normal (A) and MI (B) groups using linear regression analysis. 
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Table 5.1. Comparison of CT and CC methodologies in Normal and MI groups 
  Measurement Methodology  P Values 
 Micro-CT Catheter  
ESV (µl)    
Healthy (10) 26.3 ± 6.7 7.9 ± 1.9 <0.001 
MI (7) 83.8 ± 32.5 32.3 ± 9.9 0.005 
    
EDV (µl)    
Healthy (10) 54.3 ± 14.1 25.4 ± 6.4 <0.001 
MI (7) 109.3 ± 28.9 37.5 ± 13.4 <0.001 
    
SV (µl)    
Healthy (10) 28.1 ± 8.9 17.5 ± 5.8 0.005 
MI (7) 25.4 ± 6.3 5.3 ± 4.7 <0.001 
    
EF (%)    
Healthy (10) 51.2 ± 6.8 67.8 ± 9.4 0.003 
MI (7) 25.2 ± 9.8 12.5 ± 7.8 0.007 
    
CO (ml min-1)    
Healthy (10) 13.2 ± 3.8 8.2 ± 2.6 0.005 
MI (7) 11.2 ± 2.7 2.3 ± 2.0 <0.001 
    
HR (bpm)    
Healthy (10) 475.5 ± 38.7 475.5 ± 38.7 - 
MI (7) 441.9 ± 39.4 441.9 ± 39.4 - 
    
+dP/dtmax (mmHg s-1)    
Healthy (10) - 6060.1 ± 948.0 - 
MI (7) - 4342.1 ± 1104.8 - 
    
-dP/dtmin (mmHg s-1)    
Healthy (10) - 6701.7 ± 735.3 - 
MI (7) - 4594.0 ± 917.6 - 
Values are means ± SD; numbers in brackets represent no. of animals.  MI, myocardial 
infarction; ESV, end-systolic volume; EDV, end-diastolic volume; SV, stroke volume; EF, 
ejection fraction; CO, cardiac output; HR, heart rate; +dP/dtmax, maximal rate of LV 
pressure increase; -dP/dtmin, maximal rate of LV pressure decline. 
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The CT volumes measured prior to the insertion of the catheter (precath), during 
the CC measurements (cathscan), and following the withdrawal of the catheter (postcath) 
are plotted in Figure 5.4 for each mouse completing the study.   
 
When changes in individual animals were tracked, several mice in each group displayed 
ventricle dilation following catheter insertion, demonstrated by an increased ESV and 
EDV in the affected mice (Fig. 5.4); in some cases the volume was doubled between the 
 
Figure 5.4: Line plots for individual mice within the Normal group and MI group.  
Systolic volumes (A, B), diastolic volumes (C, D), and ejection fraction (E, F) are 
presented.  The mice with noticeable increases in LV volume are marked with blue 
lines. 
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precath image and the cathscan image, and remained increased even following catheter 
removal (postcath image).  These changes are illustrated visually in a normal mouse and 
an MI mouse in Fig. 5.5 and 5.6, respectively.  Volume increases did not correspond to 
changes in EF, however. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The averaged values for the physiological parameters measured, and the 
corresponding p values, are listed for the Normal group and the MI group in Tables 5.2 
and 5.3, respectively.  Differences between the precath and cathscan volumes were 
significant for the EDV of the MI group and approached significance for ESV for both 
Healthy and MI groups.  EF differences between the three scan times were not 
 
Figure 5.5: Coronal (A, B, C) and axial (D, E, F) slices (0.154 mm 
thick) from a 3D image of a normal mouse heart in diastole, before (A, 
D), during (B, E) and following catheterization (C, F).  A 3D isosurface 
of the catheter was overlaid on the image, shown in blue.  Note the 
large volume increase between the first (A, D) and second (B, E) scans.  
The yellow arrow points to the left atrium, enlarged following catheter 
insertion. The catheter is highly attenuating, with the electrodes causing 
streaking artefacts in several slices. 
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significantly different, except for the Normal group, which showed a decrease in EF 
during the postcath scan compared to the precath scan. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is important to note that Figs 5.5B and 5.6B represent first 3D visualization of a 
conductance catheter within a normal and infarcted mouse heart, respectively.  The 
placement of the catheter, highlighted as a 3D isosurface overlaid on the micro-CT 
images and shown in blue, is clearly seen: in both cases the catheter rests along the 
ventricular septum rather than in the optimal central position along the long axis.  The 
positioning of the catheter along the septum was seen in all mice studied, with small 
differences corresponding to variations of cardiac anatomy and position within the 
thoracic cavity related to biological variability. 
 
 
 
 
 
Figure 5.6: Coronal (A, B, C) and axial (D, E, F) images of an MI 
mouse heart in diastole, scanned before (A, D), during (B, E) and 
following catheterization (C, F).  A 3D isosurface of the catheter was 
overlaid on the image, shown in blue.  The infarct can be identified by 
the thinning wall in the apex of the heart.  Note the volume increase 
between the first and second scans. 
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Table 5.2. Comparison of physiological parameters in Normal mice before, during, and 
following catheterization, measured using micro-CT 
 Scan Type P-value 
 Precath Cathscan Postcath  
Normal Group (10)     
ESV (µl) 21.1 ± 4.2 26.3 ± 6.7 26.0 ± 7.2 0.066 
EDV (µl) 46.1 ± 6.2 54.3 ± 14.1 52.3 ± 14.2 0.187 
SV (µl) 25.1 ± 3.4 28.1 ± 8.9 26.4 ± 8.1 0.461 
EF (%) 54.6 ± 5.0 51.2 ± 6.8 50.1 ± 5.7 0.026* 
CO (ml/min) 11.7 ± 2.0 13.2 ± 3.8 12.3 ± 3.9 0.407 
HR (bpm) 467.4 ± 56.1 475.5 ± 38.7 464.2 ± 29.1 0.743 
Values are means ± SD; numbers in brackets represent no. of animals.  ESV, end-systolic 
volume; EDV, end-diastolic volume; SV, stroke volume; EF, ejection fraction; CO, cardiac 
output; HR, heart rate. 
*significance of precath vs. postcath 
 
 
 
Table 5.3. Comparison of physiological parameters in MI mice before, during, and 
following catheterization, measured using micro-CT 
 Scan Type P-value 
 Precath Cathscan Postcath  
MI Group (7)     
ESV (µl) 75.0 ± 33.8 83.8 ± 32.5 87.9 ± 37.1 0.072 
EDV (µl) 96.5 ± 34.3 109.3 ± 28.9 103.8 ± 29.8 0.031† 
SV (µl) 21.5 ± 5.7 25.4 ± 6.3 16.0 ± 10.7 0.072 
EF (%) 24.1 ± 9.7 25.2 ± 9.8 17.8 ± 13.6 0.119 
CO (µl/min) 10.8 ± 2.5 11.2 ± 2.7 6.9 ± 4.9 0.040‡ 
HR (bpm) 507.1 ± 32.0 441.9 ± 39.4 403.57 ± 65.1 0.012* 
Values are means ± SD; numbers in brackets represent no. of animals.  MI, myocardial 
infarction; ESV, end-systolic volume; EDV, end-diastolic volume; SV, stroke volume; EF, 
ejection fraction; CO, cardiac output; HR, heart rate. 
*significance of precath vs. postcath 
†significance of precath vs. cathscan 
‡significance of cathscan vs. postcath 
 
 
5.4 Discussion 
The present study represents the first time that CC-derived LV volume 
measurements have been compared to volume measurements acquired simultaneously 
using a 3D imaging technique – retrospectively gated micro-CT – in both normal and MI 
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mice.  The use of micro-CT provided two important advantages over previous studies 
comparing catheter measurements to imaging-derived measurements: 1) a single 50-
second scan provided 3D images of both end-systole and end-diastole, and 2) calculation 
of the ventricular volumes could be made without making geometrical assumptions.  The 
rapid scan time ensured that all CT and CC volume measurements could be made 
simultaneously, over a very short time period – ensuring that variations in cardiac 
function over time did not affect the comparison of the measurement techniques; such 
variations are likely to occur during prolonged periods under anesthesia, especially when 
studying mouse models of heart failure.  Since the 3D CT images were acquired with 
isotropic resolution (i.e. equal resolution in all three dimensions) no geometric 
assumptions were required – the volumes were measured directly from the 3D image, 
without the need to calculate ellipse approximations as required with 2D echo, or to 
approximate apex volume, and account for large slice thicknesses or in-flow effects, as is 
often required with MRI.  The 3D images also enable clear visualization of the entire 
catheter and its position within the LV: Figs. 5.5B and 5.6B represent the first time the 
catheter has been visualized in 3D within the ventricle of a normal mouse and MI mouse, 
respectively. 
Overall, we demonstrated that CC volumes were significantly lower than CT 
volumes.  The biases of the ESV and EDV were similar to those reported in a previous 
study where the imaging and CC methods were performed simultaneously,14 although the 
ESV bias in that study was lower  (-7 #L vs. -18.4 #L).  The difference in measured bias 
at end systole can be partly explained by foreshortening of the LV long axis in the 
echocardiographic image, resulting in a lower echo-derived LV volume and therefore a 
lower bias.  At end diastole the effects of foreshortening would be reduced (due to the 
larger overall volume of the LV), explaining the equivalent bias  (-29.1 #L vs. -28.9 #L) 
measured by the echocardiographic and CT techniques. 
The biases in the MI group were larger than in the Normal group, demonstrating 
that the measurement differences increased with larger volumes (Fig. 5.2 vs. Fig. 5.1), 
supporting the trends reported previously.13  Correct positioning of the catheter within the 
LV is critical for correct volume measurements,14 and yet visualization of the catheter in 
vivo (Fig. 5.5B and 5.6B) demonstrated that it is often placed off-center and running 
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along the septum.  In this study, the catheter was maneuvered into position in the typical 
fashion, by relying on PV loop feedback to indicate correct positioning, with no 
additional imaging feedback.  The stiffness of the catheter tip, coupled with the off-center 
position of the aortic valve, is likely responsible for the inability to position the tip 
centrally within the LV.  Accurate volume measurements also require that the distance 
between the sensor electrodes be closely matched to the length of the LV, which was not 
the case when the Millar catheter was used in the MI group, accounting for the increased 
negative bias in the measured volumes.  Catheters with varying distances between the 
sensor electrodes could be manufactured for use with dilated hearts, in an effort to reduce 
this negative bias.  Additionally, by relying on PV loop feedback to position the catheter, 
there is the potential to position the catheter is the relatively well-contracting basal area, 
further accentuating the volume underestimation of MI hearts.  Ultimately, accurate 
absolute volumes measured by conductance catheter in individual animals can only be 
obtained after calibration with an independent imaging method; however, within-group 
comparisons may still be valuable if a highly reproducible catheter positioning technique 
is employed.  
Correlation between CT and CC volumes was moderate in the Normal group, and 
low in the MI group (Fig. 5.3).  Previous studies comparing CC measurements to MRI-
acquired volumes12,13 reported higher correlations between the two techniques, even 
though the measurements were not performed simultaneously; in both cases higher 
correlation was achieved because the CC reported values were higher than those 
measured in our study.  As the parallel conductance and volume calibration techniques 
used were similar between this study and the MRI studies, we expect that the lower 
reported CC values are likely due to catheter positioning.  Nieslen et al.12 inserted the 
catheter through the apex of the ventricle, which, although necessitating a thoracotomy, 
facilitated the positioning of the catheter along the central axis of the ventricle. Winter et 
al.,13 on the other hand, used a different mouse strain (NOD/scid).  In our experience, – 
performing whole-body mouse scans – the hearts of different mouse strains tend to be 
positioned differently within the thorax and positioning of a conductance catheter 
centrally within the LV may be facilitated by the heart shape and alignment with the 
carotid artery and aorta.  Ultimately, the accuracy of catheter volumes is highly 
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dependent on the position within the LV, and this must be taken into account in 
hemodynamic studies. 
The pressure-volume conductance catheter methodology has numerous 
advantages for continuous real-time volume measurements coupled with simultaneous 
pressure measurements.  Ideally, this enables the evaluation of PV loops during loading 
interventions which results in the ability to analyze LV function in terms of systolic 
elastance and diastolic compliance.  However, inaccurate volume readings lead to 
inaccurate measurements of LV function.14  Therefore, obtaining accurate volume 
measurements is extremely important to take full advantage of the unique features of the 
conductance catheter.  As has been discussed in detail previously,14 volume 
measurements obtained using a conductance catheter rely on a constant parallel 
conductance and a constant alpha factor when in fact, these variables change in a 
curvilinear pattern during the cardiac cycle.  Although the use of constant factors does 
not appear to cause difficulties in larger animals, in mice the off-center placement of the 
catheter exaggerates the negative effects on volume measurements.  Additionally, while 
the relationship between conductance and volume is approximately linear, absolute 
volume error increases quickly when correcting for the alpha factor.  This results in either 
an overestimation or an underestimation of the final volume measurements, depending on 
how alpha was calculated (Baan’s equation or cuvette calibration, respectively).21  
Solutions have been proposed that continuously track the changes in parallel conductance 
during the cardiac cycle,22 as well as using a dynamic correction for alpha,23 giving a 
volume measurement that is less dependent on catheter positioning in the LV.   While this 
earlier work has shown excellent agreement between catheter-measurements of volume 
made using Wei’s technique in comparison to 2D echocardiographic measurements,14 
further verification – similar to the micro-CT experiments described in this study, which 
are not operator dependent – would be beneficial in ultimately verifying this newly 
available technology. 
The rapid retrospectively gated micro-CT technique also enabled the evaluation of 
the effect of catheterization on the mouse heart.  Earlier studies (e.g. Porterfield et al.) 
have presented results suggesting that LV enlargement may be occurring upon the 
insertion of the catheter (30-40% of the mice in Fig. 414 have noticeably larger LV 
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volumes).  While the averaged group results (presented in Table 5.2) show significant 
increase only in EDV in the MI group, trends towards significant differences are seen in 
ESV for both normal and MI mice.  More importantly, the results for individual mice, 
reporting LV sizes prior to and during CC insertion (Fig. 5.4), demonstrate dramatic 
increases in LV size (diastolic and systolic) in several of the mice in each of the two 
groups; in some cases LV volumes more than double following CC insertion.  In these 
mice the increase in volume did not reverse with withdrawal of the catheter.  Since a drop 
in EF was not associated with this myocardial dilation (Fig. 5.4), volume overload – 
rather than an ischemic event – is presented as a possible explanation for the LV 
enlargement.  In some images (e.g. Fig. 5.5) left atrial enlargement was observed together 
with the LV enlargement, suggesting that the overload may be due to mitral 
insufficiency.  Given the large size (0.46 mm) and stiffness of the catheter it is highly 
probable that catheterization through the aortic valve may occasionally damage the 
papillary muscle or chordae tendinae on the septal side, preventing complete mitral valve 
closure.  While the administration of incremental volumes of contrast agent, or the 
injection of saline, may also be considered as possible causes for the increase in LV 
volume, the fact that we did not observe a transitory increase in LV end-diastolic pressure 
(that would be expected to accompany LV dilation) suggests that the addition of contrast 
agent or saline did not contribute to the LV dilation observed.  Additionally, evaluation of 
the RVU values before and after injection of the two solutions demonstrated an 
insignificant change in the raw volume measurements recorded by the catheter, which 
further suggests it is unlikely the injected solutions caused the hypertrophy witnessed.  
For example, in the mouse presenting the most dramatic LV enlargement, the mean RVU 
before the injections was 18.6, and following the injections was 19.9. 
Anesthetic administration can also have an effect on the cardiovascular system; 
although induction was performed at the onset of the experiment as was not altered 
throughout, and the LV volume increased upon catheter insertion, a cumulative influence 
of anesthesia exposure cannot be excluded using the experimental design outlined in this 
study.  However, the influence of the isoflurane would be expected to be that of 
myocardial depression,24 and the findings observed were that of a preservation of 
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contractile function.  Therefore, it is unlikely that the anesthetic was a contributory factor 
in the LV dilation. 
Our results (Tables 5.2 and 5.3) also report significant differences in CO and HR 
of the MI group, and in EF in the Healthy group, between the precath, cathscan, and 
postcath time points.  These differences are attributed to accelerated heart failure during 
the postcath scan, a result of catheter removal from the LV, and not an indication of the 
catheter’s effect during hemodynamic data collection. 
Since a number of earlier studies have reported on the differences in volume 
measurement between image-derived and CC measurements, the most significant result 
presented in this study is the previously unacknowledged enlargement of the LV that 
occurs in a large fraction of mice upon the insertion of a stiff conductance catheter.  
While in this particular study the group average results did not reach statistical 
significance, the possibility that a large fraction of catheterized hearts may become 
dilated suggests that further evaluation of the effects of catheters on the myocardium is 
warranted.  Variability of mouse anatomy and surgical technique may contribute 
dramatically to the possibility that LV enlargement will occur and may ultimately affect 
important preclinical results.  The exact mechanism leading to LV dilation needs to be 
determined, perhaps using Doppler ultrasound to confirm the possible presence of mitral 
regurgitation.  Additional information regarding the nature of the catheter’s effect on the 
mouse heart will aid in further optimization of the technique, leading to a reliable method 
of ascertaining cardiac function in mice. 
 
5.4.1 Limitations 
Volume measurements acquired with a conductance catheter depend on blood 
conductivity, and any solution injected that alters that conductivity and is not accounted 
for may result in an inaccurate volume measurement.  Two solutions – contrast agent and 
hypertonic saline – were injected during this study resulting in a potential to cause 
inaccurate readings.  The hypertonic saline has a higher conductivity than blood plasma, 
and if it was administered just prior to blood collection, it may cause a problem.  
However, in this study the saline was injected approximately 10 minutes prior to 
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measurement acquisition: we waited until the volume signal had returned to baseline 
before proceeding with the experiment; therefore it is highly unlikely the saline injection 
caused the volume underestimations.  The contrast agent was specifically designed to 
remain in the bloodstream for an extended period of time, therefore having the potential 
to alter blood conductivity.  However, following injection, the volume measurements 
acquired were not significantly different from those measured before the injection, 
indicating that the conductance had not significantly changed.  In addition, the volume 
measurements we report were in the same range as a number of other studies11, 12, 14, 25, 26 
that did not use a contrast agent.  Therefore it is highly unlikely the contrast agent 
contributed to the volume underestimation we witnessed. 
The catheter was left in the heart during two scans, but we believe this had no 
impact on cardiac function, as catheters are routinely left in the ventricle during IV 
occlusions, which can last 15-30 minutes.  Load-independent PV relationships were not 
acquired, resulting in an absence of information regarding myocardial contractility.  
However, the large volume underestimations recorded would have made any PV 
relationships unreliable.14    
 
5.4.2 Conclusion 
Conductance catheters, although invasive, offer the potential to measure cardiac 
dysfunction in mice in a way not possible with imaging methodologies.  However, the 
underestimated volumes measured, at times quite dramatic, have an impact on the 
sensitivity and accuracy of the data collected.  The measured volume is highly reliant on 
catheter position, which in turn is affected by the method of insertion, and the mouse 
model employed in the study.  Catheterization led to LV enlargement in a large fraction 
of mice undergoing CC evaluation which, although not significant at the 0.05 level, was 
potentially due to the catheter insertion combined with the mouse strain used.  Such LV 
enlargement may affect many catheter-based studies that are performed “blindly” – i.e. 
with no knowledge of the catheter position during measurement – and further studies are 
required to confirm the occurrence of LV enlargement.  
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6 Summary and Future Work 
 
6.1 Summary 
Cardiac-gated micro-CT is a non-invasive imaging technique capable of 
producing high-resolution images of the mouse heart, in scan times of less than one 
minute.  Cardiac structure and function can be assessed, using both qualitative and 
quantitative measurements, and the non-invasive nature of the technique facilitates its use 
in longitudinal studies. 
 
6.1.1 Chapter 2: Longitudinal Follow-up of Cardiac Structure and Functional 
Changes in an Infarct Mouse Model using Retrospectively Gated Micro-
computed Tomography 
Chapter 2 demonstrates that retrospectively gated cardiac micro-CT can be used 
to precisely identify differences in left ventricular (LV) volume and heart function 
between myocardial infarcted (MI) and sham mice, and that these differences can be 
followed longitudinally in individual mice.  Qualitative, structural differences were 
visualized between the sham and the MI mice, with the MI mice demonstrating cardiac 
enlargement as early as one week post-surgery; the infarct was also clearly defined as the 
thinning portion of the wall in the apex of the heart.  These qualitative differences 
translated quantitatively into small changes that could be precisely measured and tracked 
over the four-week study.  Both intra- and inter-observer variability when measuring 
volumes were low, indicating excellent reproducibility of measurements.  Intra-subject 
measurements also showed good reproducibility, with variation in volumes of infarcted 
hearts being slightly higher than variations in sham-operated hearts; this was attributed 
the rounded shape of the LV in the MI mice, making identification of the LV boundary at 
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the base of the heart (for the purpose of drawing contours around the LV) more 
challenging.  
Micro-CT has low soft tissue contrast, but with the addition of a contrast agent, 
the boundaries of the myocardial wall were clearly delineated.  This enabled LV mass 
measurements, which showed significant differences between the sham and the MI mice; 
this type of measurement also provides a method for identifying the degree of cardiac 
hypertrophy present. 
Volume and ejection fraction measurements from the micro-CT images were also 
compared to measurements acquired using a pressure-conductance catheter.  Although 
the trends between the two measurement techniques were similar (i.e. larger volumes and 
lower function in MI mice), the volume measurements of the catheter were drastically 
lower than those of the micro-CT images.  Although originally intended as a verification 
of the micro-CT values, the clearly inaccurate volumes of the catheter eventually led to 
an evaluation of the method, detailed in Chapter 5. 
 
6.1.2 Chapter 3: Evaluation of eXIA 160 Cardiac-related Enhancement in 
C57BL/6 and BALB/c mice using Micro-CT 
eXIA 160 is a relatively new blood-pool contrast agent; a high iodine 
concentration makes it possible to administer a low volume of contrast to the mice, 
reducing potential negative hemodynamic effects.  Chapter 3 details the time-course 
enhancement of eXIA in both C57BL/6 and BALB/c mouse strains; overall, this agent 
proved to be an excellent choice for use in cardiac micro-CT studies, with similar 
enhancement values witnessed in both strains.  A high level of enhancement (over 650 
HU above the precontrast values) was measured within 5 minutes of injection; the 
enhancement dropped 40% within the first hour, but the values remained above 500 HU 
during the first 30 minutes post-injection, providing excellent contrast for a period of 
time sufficient to perform cardiac-gated micro-CT scans. 
One of the rather unique, and unexpected, qualities of eXIA 160 was its 
enhancement of the myocardium, possibly a reflection of one of the ways the agent is 
metabolized in the mouse.  Enhancement began immediately following injection, and 
continued to increase until peaking at four hours post-administration with a value above 
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270 HU.  The increasing enhancement during the first hour did result in decreased 
contrast between the myocardium and the blood-pool, effectively shortening the period of 
time during which scans measuring cardiac function could be acquired.  However, the 
myocardial enhancement also offers a number of possibilities for further study, including 
accurate measurement of myocardial mass independent of manual tracing, and the ability 
to study wall motion and wall function, not normally feasible with micro-CT.  eXIA 160 
can therefore act as a dual-phase cardiac contrast agent, with scans evaluating LV volume 
and cardiac function acquired within the first 30 minutes of injection, and later scans 
intended for wall motion studies acquired four hours post-injection. 
 
6.1.3 Chapter 4: X-ray dose delivered during a longitudinal micro-CT study has 
no adverse effects on cardiac and pulmonary tissue in C57BL/6 mice 
One of the concerns associated with using cardiac micro-CT is the x-ray dose 
delivered to the animal during the scan; this becomes especially relevant in longitudinal 
studies were the mouse is scanned multiple times.  A number of studies have been 
performed that evaluate the effect of radiotherapy-level doses (10-20 Gy) on the 
mouse,1,2 but the dose delivered and the time frame during which observation took place 
in these studies makes it difficult to apply the results to a micro-CT study.  Chapter 4 
examined the effect of the dose delivered during a cardiac micro-CT study on cardiac and 
pulmonary tissue in C57BL/6 mice.  The mice in the Irradiated Group were scanned 
weekly, with each scan session comprised of three retrospectively gated scans, for a total 
of six weeks.  The weekly entrance dose delivered to the mice was 0.84 Gy, with a total 
dose of 5.04 Gy delivered over the six weeks.  Overall, there were no significant changes 
to the heart or lungs in the Irradiated Group at week six, compared to the Control Group; 
this was reflected both in the micro-CT scans and, more significantly, in the histological 
specimens of myocardial and pulmonary tissue prepared following the week six scans.  
There was no evidence of early inflammation occurring at a cellular level, confirming 
that micro-CT can be safely used in longitudinal studies without concern that the dose 
delivered will have adverse effects on the mouse’s health. 
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6.1.4 Chapter 5: Rapid micro-computed tomography suggests cardiac 
enlargement occurs during conductance catheter measurements in mice 
Conductance catheters (CC), although invasive, offer the potential to measure 
cardiac dysfunction in mice in a way not possible with imaging methodologies.  
However, in the study described in Chapter 2, CC-derived volumes were greatly 
underestimated compared to micro-CT derived volumes.  CC volume underestimation 
has also been reported by several groups that compared catheter measurements to MRI-
derived measurements (MRI and catheter measurements were acquired up to two days 
apart).3-5  Chapter 5 details a study that makes use of the advantages of cardiac micro-CT, 
including the rapid scan time, and the ability to evaluate the heart both qualitatively and 
quantitatively from high-resolution isotropic images.  The rapid scan time made it 
possible to scan the mouse with the catheter in place recording its pressure-volume 
measurements, which enabled a comparison between simultaneously acquired CT- and 
CC-derived volumes.  The ability to scan the mouse with the catheter in place also 
facilitated an evaluation of the effect catheterization has on the mouse heart.  This was 
accomplished by acquiring micro-CT scans before, during, and after catheterization. 
The CC-derived volumes were found to be dramatically underestimated compared 
to the CT-derived volumes, confirming the results previously reported.  Visualization of 
the catheter within the LV in the micro-CT images illustrated that the catheter is often 
placed off-center in the chamber; given that CC-derived volumes are highly reliant on 
catheter position,6 this gives an explanation for the observed underestimation. 
Catheterization of the mouse heart was found to cause LV enlargement in 40% of 
the mice: comparing the LV in micro-CT images acquired before catheter insertion, to the 
LV in images with the catheter in place, demonstrated an increase in volume that in some 
mice was almost doubled.  Given that the ejection fraction remained the same, regardless 
of the severity of enlargement, it is proposed this volume increase was due to mitral 
regurgitation as a result of damage caused during catheter insertion.  The average change 
in LV volume in the group of mice studied was ultimately found to be not significant at 
the 0.05 level; however, given that catheter placement within the LV is highly dependent 
on the anatomy of the mouse, which can vary between strains, the results presented may 
have significance to other catheter studies.  
105 
 
6.2 Future work 
As detailed in Chapter 3, eXIA 160 has the unique property of enhancing the 
myocardium beyond a time when the contrast agent has been eliminated from the blood-
pool, creating a reverse contrast with a bright wall and unenhanced blood.  This offers a 
number of opportunities for evaluating the LV wall, normally challenging in micro-CT 
images given the low soft tissue contrast.  LV mass may be more accurately measured, as 
the enhancement would enable automatic segmentation, rather than relying on manually 
traced contours.  Evaluation of wall motion and wall function may also be possible; given 
that this would most useful in mouse models that display abnormal wall function, the first 
step would be to determine the extent of myocardial enhancement in such a model; for 
example, in a mouse model of myocardial infarction.  Initial results indicate that 
enhancement of the infarcted area does not occur, which would limit the types of 
evaluation possible.  However, if this agent was combined with conventional contrast 
agent that extravasates into the infarct, as described by Narhendorf et al.,7 this may 
provide a solution that enables wall motion studies to be performed. 
In Chapter 4, it was determined that the x-ray dose delivered during a longitudinal 
micro-CT study has no adverse effects on the mouse.  What is unclear, however, is how 
the dose will affect cancer mouse models.  Longitudinal evaluations of tumor growth, 
regression, or metastasis are necessary for evaluation new therapeutic approaches,8, 9 and 
what needs to be determined is how the dose delivered during a micro-CT study will 
affect tumor growth.  There is the potential that the radiation dose may influence the fast-
growing cancer cells, confounding the investigation of treatment therapies.  A study 
similar to the one described in Chapter 4, using a tumor model, should be carried out to 
investigate the possibility. 
This thesis has described the use of cardiac micro-CT to quantitatively and 
qualitatively evaluate mouse models of heart disease in longitudinal studies.  Although 
micro-CT excels at evaluating cardiac structure, and providing accurate volume 
measurements not reliant on geometric assumptions or approximations, the level of 
information acquired regarding function can be somewhat limited.  Hemodynamic studies 
are not possible, which have a greater sensitivity to changes in myocardial function10 and 
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are often used in physiology labs.  High-frequency echocardiography, on the other hand, 
is an imaging method that, although providing similar resolution to micro-CT, does not 
visualize cardiac structure as clearly.  It does, however, have the ability to measure 
hemodynamic function non-invasively in mice, using Doppler imaging.11  It would 
therefore be beneficial to try and create a protocol for using the two imaging modalities 
in one study, combining the advantages of each.  This has the potential of providing 
physiologists with a non-invasive methodology for performing the measurements they 
find valuable, with the added benefit of excellent structural information, as an alternative 
the invasive methods currently employed. 
 
6.3 Conclusion 
Cardiac-gated micro-CT is a rapid, reproducible imaging technique capable of 
quantifying changes in cardiac structure and function over time. This enables the 
longitudinal evaluation of disease progression in mouse models of cardiac disease, with 
the added possibility of assessing wall motion and function, due to the unique 
characteristics of new contrast agent.  The x-ray dose delivered during the a longitudinal 
study is sufficiently low that no early signs of radiation damage are observed at a cellular 
level, indicating that micro-CT can be safely used without concern that the radiation dose 
will affect the outcome of the study.  This imaging technique can also be used to evaluate 
other methods of assessing cardiac function, providing both qualitative and quantitative 
measurements.  Overall, cardiac-gated micro-CT offers a number of advantages, and is 
proving to be valuable tool in cardiovascular disease research. 
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Appendix A 
Fast Retrospectively Gated Quantitative 4D Cardiac 
Micro CT Imaging of Free-breathing Mice 
The content of this chapter is adapted from “Fast retrospectively gated 
quantitative 4D micro CT imaging of free-breathing mice”, published in Investigative 
Radiology, vol 42 (2) February 2007, by Maria Drangova, Nancy L. Ford, Sarah A. 
Detombe, Andrew R. Wheatley, and David W. Holdsworth.  It has been included as 
background for the gated micro-CT methodology used in this thesis. 
 
Introduction 
Mouse models play an important role in the study of cardiac disease and its 
potential treatment, and would benefit from the ability to quantify myocardial function 
and structure during longitudinal studies.  The challenges of generating images of the 
beating mouse heart relate to the small size of the heart (the left ventricle of an adult 
mouse is less than 4 mm in diameter), the rapid respiratory rate, and the rapid cardiac 
cycle (up to 600 beats per minute). 
Currently, magnetic resonance imaging (MRI) is available for the study of 
myocardial function and structure but the studies are time-consuming, requiring up to an 
hour to acquire 6-8 images of 1-mm thick slices through the heart, with in-plane 
resolution ranging between 50 and 120 #m;1-4 more time-efficient MRI techniques to 
image multiple mice simultaneously are being developed.5  Recently Dawson et al.4 
introduced a 3D-echocardiographic technique capable of acquiring 10-18 gated short-axis 
views of mouse myocardium, spaced 500 #m apart, in less than 5 minutes.  However, 
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neither the MRI nor echocardiographic techniques offer isotropic resolution, with slice-
thickness equal to the pixel dimension in plane.  In a recent publication, Badea et al. 
described a micro computed tomography (micro-CT) technique for generating four-
dimensional (4D) images of the murine heart with 90-#m isotropic voxel size, using a 
prototype micro-CT scanner.6, 7  This micro-CT technique combines the benefits of 
dynamic acquisition with isotropic, 3D, high-resolution images, thereby providing 4D 
images of the heart that have not been possible with either echocardiography or MRI.  
The technique requires the animal to be mechanically ventilated, positioned vertically, 
and rotated throughout the scan, while triggered projection images are acquired.  Scan 
times for this prospectively triggered acquisition are on the order of 10 minutes, 
depending on the heart rate and ventilation-cycle length.  
The most recent technical advances in micro-CT have focused on the 
implementation of area detectors mounted on a clinical slip-ring gantry, making the 
continual acquisition of projection data possible and thereby enabling the rapid 
acquisition of volumetric scans.8, 9  Such scanners have been used for rapid (8 second) 
anatomical imaging10 but the lack of respiratory and cardiac gating for such systems 
limits their application for cardiac imaging. 
In this study, we present a retrospectively gated micro-CT imaging technique that 
enables the acquisition of 4D cardiac images, (i.e. 3 spatial dimensions plus resolution in 
the temporal dimension) in less than one minute in free-breathing mice.  We use a state-
of-the-art volumetric CT scanner, which utilizes a flat-panel detector mounted on a slip-
ring gantry.  Combining the capabilities of this device with physiological monitoring and 
retrospective sorting of the projection data, we have been able to demonstrate 4D cardiac 
images in mice with isotropic 150-#m voxels and temporal resolution of 12 ms..  The 
purpose of this paper is to describe the retrospectively gated micro-CT technique and 
demonstrate its effectiveness in measuring cardiac functional parameters, such as left-
ventricular ejection fraction (EF), stroke volume (SV) and cardiac output (CO), in a 
cohort of healthy mice. 
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Methods 
Animal preparation 
All animal studies were approved by the Animal Use Subcommittee of the 
University Council on Animal Care at our institution.  Five female C57BL6 mice, 
weighing approximately 20 g each, were anesthetized using approximately 1.5 % 
Isoflurane in O2.  A micro catheter was placed in a lateral tail vein for the administration 
of contrast agent.  Pediatric ECG electrodes (2269T, 3M Health Care, St. Paul, MN), with 
radiolucent carbon-fiber leads, were affixed to the paws to monitor the ECG waveform.  
The mice were positioned prone on a custom-made bed that was connected to a pressure 
transducer, which was designed to measure the motion of the diaphragm and thereby 
provide a respiration-gating signal.  The respiration-monitoring bed is described in detail 
by Ford et al.11  Both the ECG and respiratory signals were measured and recorded using 
a physiological monitoring and triggering system (BioVet, Spin Systems, South Brisbane, 
Australia).  The mice were not intubated and were allowed to breathe freely throughout 
the experiment.   
Approximately 5 minutes prior to scanning, a blood-pool contrast agent, Fenestra 
VC [50 mg I/ml] (Alerion Biomedical, Inc., San Diego, CA) was administered 
intravenously at a dose of 0.02 ml/g body weight, as recommended by the manufacturer.  
This iodinated contrast agent has been shown to provide significant enhancement of the 
mouse vasculature (as high as 700 HU at the administered dose)7 for up to 2 hours post 
injection.10, 12, 13  
To evaluate the reproducibility of the functional parameters obtained using this 
technique, each mouse was scanned three times, as described below, with repositioning 
between scans. 
 
Image acquisition 
Images were acquired using a volumetric cone-beam micro-CT scanner (Locus 
Ultra, General Electric Healthcare, London, ON, Canada).  The scanner uses a 
1024!1024-element flat-panel detector and a clinical x-ray tube mounted on a slip-ring 
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gantry to enable continuous rotation about the object.  Mice were positioned at the centre 
of the scanner, to reduce the effect of radial blur caused by the rotation of the gantry 
during image acquisition.  For the volumetric CT application described here, only the 
central 1024 ! 360 detector elements are read out.  Projection images were acquired at 
80 kVp and 50 mA, with 0.15-mm added copper filtration, over a field of view of 14 cm 
(transaxial) x 5.4 cm (longitudinal).  For retrospectively gated imaging, projection images 
were acquired over 10 complete rotations (3600°) at a rate of 5 seconds per rotation, for a 
total scan time of 50 seconds.  For each rotation, 416 projection images spaced at 0.86° 
intervals were acquired, at a frame rate of 12 ms/projection.  Bright- and dark-field 
projection images were also acquired, prior to each scan, to correct the data for detector 
non-uniformities.  To estimate the entrance dose delivered during the scans, the entrance 
exposure rate at 80 kVp was measured using a 15-cm3 ion chamber (model 96035, 
Keithley, Cleveland, OH) placed near the isocentre of the scanner and an electrometer 
(model 617, Keithley, Cleveland, OH). 
In the continuous-rotation acquisition mode of the Locus Ultra, the first projection 
image is acquired a known-delay after the x rays are turned on.  Therefore to synchronize 
the physiological signals with the image acquisition, an x-ray monitor, constructed by 
mounting a piece of x-ray fluorescent screen on a photo-diode, was placed near the edge 
of the x-ray field and positioned so that it detected scattered x-ray photons.  The signal 
from the x-ray monitor was recorded simultaneously with the respiratory and ECG 
waveforms using the BioVet system at a rate of 1 kHz, thereby enabling the 
synchronization of the physiological waveforms and the acquired projection images. 
 
Retrospective Gating and Reconstruction 
Analysis of the ECG, respiratory, and x-ray monitor signals was performed using 
Matlab (The MathWorks, Natick, MA, USA).   Figure 1 represents a sample set of ECG 
and respiratory waveforms recorded during acquisition, along with the main processing 
steps described below  First, the respiratory waveform, resp(t), was analyzed to determine 
the periods of end expiration: after smoothing the waveform by a 30-ms boxcar  window, 
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the first derivative dresp(t)/dt was calculated and the peaks of the respiratory waveform 
were determined from the zero-crossings of dresp(t)/dt (Fig. 1b).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The maximum (max) and minimum (min) respiratory excursion for each breath were then 
calculated and expiration was considered to be the time period over which resp(t) < (min 
+ F (max – min)), where F is a factor selected to define the expiration period.  For the 
studies described here, F was set to 0.2.  The ECG waveform was analyzed in a similar 
fashion, by smoothing the ECG waveform (10 ms window), calculating the derivative of 
the waveform (Fig. 1d) and considering the inflection point just prior to the peak (R-
wave) to be the start of the cardiac cycle.  
Figure 1: Sample subset of ECG and 
respiratory waveforms recorded 
during image acquisition.  (a) 
Respiratory signal, (b) derivative of 
respiratory signal used to identify the 
peaks of resp (t), (c) the end-
expiration period identified in each 
cycle, (d) measured ECG signal, (e) 
derivative of the ECG signal, and (f) 
the time points identified as the start 
of each cardiac cycle, based on the 
inflection point just prior to each R-
wave.  The start of the cardiac cycle 
is depicted only for cycles occurring 
during end expiration.  Note that the 
waveforms shown in (a) and (d) have 
been smoothed by a 30 ms and 10 ms 
boxcar window, respectively, as 
described in the text. 
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The projection data were then sorted and only unique projections falling within a 
predetermined cardiac window were used to reconstruct a 3D image, corresponding to a 
specific time point of the cardiac cycle.  Three-dimensional images were reconstructed 
for each frame in the cardiac cycle using the reconstruction engine of the Locus Ultra.  
The cardiac window width (W) was chosen to be 12 ms, based on the acquisition time for 
each projection; for this study, 10-14 frames were reconstructed per cardiac cycle, 
depending on the heart rate.  Note that W does not have to equal the acquisition window 
width and can be selected retrospectively.  However, selecting a wider W will lead to 
increased temporal blurring.  For comparison purposes, an ungated scan was also 
reconstructed from the first 360° of projection images.  Although an ungated scan can be 
reconstructed from the entire 3600° data set, we believe that, in terms of SNR, 
comparison of an ungated image reconstructed from one rotation (1/10 of all acquired 
data) to the gated images is more appropriate.  All images were reconstructed on a 256 ! 
256 ! 360 matrix, providing an isotropic voxel spacing of 150 #m ! 150 #m ! 150 #m. 
 
Image Analysis 
Images were analyzed using MicroView analysis software (MicroView v2.2, 
General Electric Healthcare, London, ON, Canada).  A single operator reoriented the 3D 
images to align with the long/short axis of the left ventricle (LV).  For LV volume 
calculation, an automated region-growing algorithm was used to isolate the chamber of 
the left ventricle and calculate volume.  Otsu’s automatic thresholding algorithm14 was 
used to determine the threshold CT number separating the LV chamber from 
myocardium; for experiments reported on here, the average threshold value was 306 ± 73 
HU.  Automatic region growing was terminated at the aortic valve, and in regions near 
the base of the heart, where “bleeding” of the region into the neighbouring atria occurred, 
by manually drawing a region to limit the automatic region-growing operation.  The same 
operator who re-oriented the images drew the regions used to constrain the automatic 
region-growing algorithm.  To define the time points corresponding to systole and 
diastole, the LV volume was calculated throughout the cardiac cycle to determine which 
frames had the minimum and maximum LV volume, respectively.  Left-ventricular 
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systolic volume (LVSV), left-ventricular diastolic volume  (LVDV), stroke volume (SV 
= LVDV – LVSV), ejection fraction (EF = SV/LVDV) and cardiac output (CO = SV * 
heart rate) were calculated for each mouse.  
 
Statistical Analysis 
For all reported parameters the mean and standard deviation were calculated 
based on a single scan for each mouse, thereby demonstrating the inter-subject variability 
of the parameters in this cohort of mice.  This inter-subject standard deviation was used 
to determine the power of future studies and the required sample sizes.  To calculate the 
technique’s reproducibility (intra-subject), the average standard deviation of the results 
from the three repeat scans, for each mouse, was also calculated for the functional 
parameters.  Lastly, an unpaired t-test was performed to compare our results for the 
functional parameters to those published by Badea et al.7 
 
Results 
All reported results, except for the reproducibility results, are for one scan per 
mouse.  The average heart rate in this study was 405 ± 34 beats per minute.  The average 
respiratory rate of all mice scanned was 51 ± 46 breaths per minute; the average of four 
of the mice was 30± 4.7 and the fifth mouse had a respiratory rate of 131 breaths per 
minute, therefore accounting for the large standard deviation.  For each scan, 
approximately 80 percent (ranging between 65% and 85%) of the 50-s acquisition 
occurred during expiration.  Figure 2 demonstrates, for one time point in the cardiac 
cycle, how projection-data space was filled by adding more projection views following 
each rotation of the gantry.  On average, 326±35 projections were available to reconstruct 
an image at each time point in the cardiac cycle (the maximum/minimum number of 
views available were 375/257); the missing views resulted in streaking artifacts (as 
discussed below).  The entrance dose delivered for each 50-second scan was calculated to 
be 28 cGy, based on the entrance exposure of 0.013 RmA-1s-1 that was measured at the 
isocentre. 
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Figure 3 demonstrates example systolic and diastolic images acquired for one of 
the mice studied.  The images presented have been reformatted to depict the heart in a 
long-axis and short-axis view; because the acquired images have isotropic voxels, the 
same image quality is possible for all reformatted planes.  A series of short- and long-axis 
images are presented in Fig. 4, corresponding to seven time points in the cardiac cycle 
4(b-h) for one of the mice imaged, along with a pair of ungated images (Fig. 4(a)).  Note 
the excessive blurring in the myocardium, as well as near the lung/liver interface, in the 
ungated images compared to the gated ones.   
 
 
 
 
Figure 2: Histograms 
representing the filling of 
projection data space with 
each additional rotation of the 
scanner: the angular positions 
of each valid projections were 
binned into 5° histogram bins.  
Because the angular interval 
between projections was 
0.86°, the maximum number 
of projection images per bin 
(frequency) was 6.  The 
number of rotations 
contributing projection images 
to the reconstruction is 
identified in the top right hand 
corner of each graph.  The 
histograms presented are for a 
single time point during the 
cardiac cycle of one mouse.  
Note that the bin width was 
selected for illustration 
purposes only and did not 
affect the selection of valid 
projection views. 
116 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The collage in Fig. 5 is a series of contiguous 150-#m thick slices parallel to the 
long-axis, compiled to demonstrate the 3D nature of the reconstructed images and the 
detail with which cardiac structure can be identified in the 3D, high-resolution, gated 
images.  Relevant anatomical features that are easily distinguished are identified in the 
figure. 
The average signal-difference observed between the myocardium and the blood-
pool in the gated images was 360 ± 27 HU and the average noise measured in the 
myocardium was 36 ± 4.6 HU, resulting in a signal-difference-to-noise ratio of 10.4 ± 
1.6.  The noise in the gated images increased by a factor of 1.4 when compared to the un-
gated images due to the artifacts generated by the missing views.  Noise was measured in 
an air region defined just above the mouse heart; it should be noted that the artifact level 
varies depending on the object, and therefore on the position of the region of interest, and 
was most pronounced in the air regions outside the mouse.  For the mice studied, the 
 
Figure 3: Reformatted mid-ventricular short (a,b) and long 
(c,d) axis images of a mouse heart at systole (a,c) and diastole 
(b,d).  Note that all chambers of the heart, the aorta and 
structures such as the papillary muscles are easily identifiable in 
the images.  These images represent 150-µm sections taken 
from the 3D volumes reconstructed at each time point.  The 
voxel spacing in-plane is also 150 µm. 
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measured and calculated cardiac functional parameters are listed in Table 1; the table 
presents both the inter-subject variability as well as the intra-subject variability based on 
repeat scans.  Note that for all functional parameters, the standard deviation derived from 
a single scan of multiple mice (reflecting the inter-subject variability) is the same or 
larger than the standard deviation for repeat scans on the same animals (reflecting 
underlying measurement reproducibility).  
 
Based on the measured inter-subject standard deviations, a sample-size 
calculation was performed to estimate the sensitivity to differences between study groups.  
With the measured inter-subject variability of 4.6%, EF differences of 9.3% between two 
groups of 5 animals can be determined at a significance level of 0.05 with a power of 
80%; this minimum detectable difference reduces to 6% when the number of animals per 
 
Figure 4: A series of long and short axis images are presented to demonstrate the 
dynamic nature of the acquisition.  The images in (a) were reformatted from an ungated 
image obtained from the 1st of 10 rotations; Images (b) through (h) represent the heart at 
12-ms intervals starting with systole in panel (b) and covering the first 90 ms of the 
cardiac cycle.  Note the poor delineation of the myocardium in the ungated images (a), 
especially in the region of the left free wall (arrow), when compared to the time-
resolved images. 
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group is increased to 10. For longitudinal studies, where paired comparisons can be 
performed, the difference in EF that can be detected – with a sample size of 5 animals in 
a group and expected correlation of 0.8 between measurements (say, at weekly intervals) 
– reduces to 4%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Collage of adjacent 150-µm thick coronal slices covering the 
entire extent of the heart, in the systolic phase, in the anterior-posterior 
direction.  The collage demonstrates the isotropic resolution of the images 
and the high image quality over the entire volume.  The image in the top 
left corner is the most anterior slice and the one in the lower left corner – 
the most posterior slice.  The arrows identify the following cardiac/vascular 
structures: right atrium (1), right ventricle (2), left ventricle (3), left atrium 
(4), ascending aorta (5), superior vena cava (6), inominate artery, 0.6 mm 
diameter (7), papillary muscle, 0.4 mm diameter (8), left jugular vein (9), 
pulmonary trunk (10), right pulmonary vein and branches (11), and the 
inferior vena cava (12). 
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Table 1. Average functional parameters (mean ± SD) 
measured in free-breathing mice (n = 5) during a 50-s scan.  
Parameter  
LV volume, systole (µl) 19.5 ± 5.2 
LV volume, diastole (µl) 49.4 ± 7.6 
Ejection fraction 0.61 ± 0.06 
Stroke volume (µl)) 29.9 ± 5 
Cardiac output (ml/min) 12.4 ± 0.8 
 
Discussion 
In this paper we have presented the first use of a volumetric micro-CT scanner to 
acquire dynamic 3D cardiac images in free-breathing mice.  The images, which took less 
than one minute to acquire, provide the ability to measure cardiac function in 
experimental mice, under typical physiological conditions, without the necessity to 
intubate the animals or place them in unnatural positions.  The high speed of the 
technique makes it an ideal candidate for high-throughput studies for phenotype 
characterization, as well as for the study of diseased animals in short anesthesia periods, 
since scanning takes less than one minute.  The functional measurements (LVEF, CO, 
etc.) that can be obtained in lightly anesthetized mice, from retrospectively gated micro-
CT scans as described here, are equivalent to the type of measurements routinely 
performed clinically in humans, thereby making the technique an excellent candidate to 
follow cardiac function in models of disease; any findings in such models would be 
directly applicable to the clinical setting where the same functional measurements can be 
made. 
This new cardiac imaging technique depends on the use of a novel slip-ring 
mounted micro-CT scanner.  The voxel size of the reconstructed images is dependent on 
the scanner geometry and detector pixel size.  Note that voxel spacing alone does not 
determine the effective spatial resolution of the system, which depends on geometric 
parameters, focal spot size and reconstruction algorithm.  A detailed investigation of 
spatial resolution for this type of CT scanner has recently been published by Ross et al.,15 
who report the 10% cutoff of the modulation transfer function as ranging between 19 and 
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31 cm-1; this result is consistent with our own measurements of the scanner’s resolution.16  
To characterize any possible degradation in resolution (including the effects of temporal 
blurring) resulting from the retrospective gating, further studies are required.  A 
technique to study the temporal resolution of a dynamic micro-CT scanning system has 
been previously described by our group and could be applied to this retrospective gating 
technique.17 
The benefits of performing retrospective, rather than prospective, gating for mice 
are similar to those observed in human imaging: retrospective gating enables all time 
points within the cardiac cycle to be imaged and the entire cardiac cycle is imaged during 
one scan.  Retrospective gating has most frequently been applied to human cardiac MRI, 
but was recently implemented in mouse cardiac MRI5; in that study multiple mice were 
imaged simultaneously, making prospectively triggered acquisition difficult.  The rapid, 
retrospectively gated micro-CT technique described here has been applied to a single 
mouse in one scan, but could be adapted to multiple-mouse scanning, provided the 
respiratory and ECG signals of each mouse are recorded separately.  However, it is not 
clear that the added complexity of implementing multiple-mouse micro-CT is necessary, 
given that a single mouse can be imaged in less than one minute.  Retrospective gating is 
also amenable to self-gating techniques, where the raw projection data is used to 
determine the phase of the cardiac and respiratory cycles.18, 19 
The cardiac functional parameters calculated based on the micro-CT images 
(Table 1) compare closely with previous measurements of cardiac function in mice.  In 
the most direct comparison of the results presented here, with the measurements made by 
Badea et al. who used the same contrast agent, the measured values for LVSV, LVDV, 
stroke volume, and cardiac output were not significantly different from our results (p > 
0.1 for all parameters, t-test).7  Our EF was higher by approximately 14%, when 
compared to that reported by Badea,7 but agrees well with values reported by others.2, 4  
The small difference may be attributed to differences in identifying the extent of the LV 
chamber in the images.  The voxel spacing attained with the prototype-CT scanner 
described by Badea was 90 #m, compared to 150 #m for the Locus Ultra.  The good 
agreement in physiological parameters measured by the two techniques suggests that the 
larger nominal voxel size is not the limiting factor in attaining accurate measurements of 
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cardiac function.  The results reported in this study also compare closely to previous 
measurements using in vivo MRI.  The slice thickness achievable using the volumetric 
micro-CT scanner is about 6 times smaller than the typically used MR slice thickness, 
leading to the ability to realign the volumetric images with the long-axis of the heart 
following reconstruction, with no loss in image quality.  If the micro-CT images were 
averaged to mimic the typically used MRI slice thickness, a further reduction in dose is 
achievable.20  Because of the requirement to reorient the images post-reconstruction in 
order to align the images with the long/short axis of the myocardium, voxel averaging 
would optimally be performed on the reoriented images. 
Repeat measurements of the functional parameters of each mouse in three 
consecutive scans, performed after repositioning of each mouse, indicated very low intra-
subject variability (see Table 1).  For all functional parameters the intra-subject 
variability was lower than or the same as the inter-subject variability (calculated from one 
scan for each mouse), suggesting that biological variability is the dominant effect in these 
experiments.  The inter-subject variability determined in this paper, for the different 
physiological parameters, can be used in the future to plan studies with the appropriate 
number of animals required to prove a specific hypothesis.  As demonstrated in the 
presented power calculations, longitudinal studies – with 80% power – can be performed 
with as few as 5 animals per group when weekly changes of as little as 4% in EF are 
expected, thereby making this technique an ideal candidate for following both the 
progression and regression of disease. 
The technique presented here is the only micro-CT technique available to image 
the mouse myocardium under conditions of free breathing.  By not requiring intubation, 
this technique allows for frequent scans in longitudinal studies of cardiac function, 
without the possibility of inducing unnecessary damage to the mouse trachea, and 
reduces the amount of time during which the mouse is anesthetized, thereby reducing the 
adverse effects of prolonged anesthesia. Furthermore, by enabling scanning during free 
breathing, our technique can ensure that the function of the heart is evaluated in a 
physiological state that is as close as possible to the natural state of the mouse, provided 
anesthesia is maintained at a low level.21-23  In the current study, the respiratory rates 
varied over a wide range, indicating that the technique can successfully reconstruct 4D 
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cardiac images under most conditions.  Further studies, investigating the effect of 
respiratory and cardiac rate on image quality, will indicate the range of breathing rates 
over which image artifacts are minimized. 
The 12-ms temporal window currently achieved may excessively blur the images 
during systole, but is similar to that used by Badea et al.,7  The GE Locus Ultra is capable 
of rotating at speeds of up to 1 revolution per second, and acquiring projection images 
(albeit with a reduced longitudinal field of view) every 2 ms..  When this acquisition 
mode is available, we will investigate the optimal scanning protocol to maximize the 
number of views acquired per cardiac frame, and minimize the temporal acquisition 
window, while maintaining the dose to the animal at or below the currently achieved 
level of 28 cGy.  It should also be noted that blur in the images obtained with this 
technique results both from the motion of the heart during the acquisition window and 
due to the scanner gantry motion during the acquisition of each projection; faster rotation 
speeds are expected to reduce added blur due to both effects, although detector lag 
associated with flat-panel devices24 must also be considered.  Faster rotation speed may 
also prove optimal in terms of providing a greater number of valid projection views 
(during expiration and the selected cardiac phase) during acquisition.  
In the current implementation of the technique, only unique projection views are 
utilized, where for each cardiac time-point only data corresponding to at most one 
complete 360° rotation are used.  However, because temporally resolved images were 
reconstructed over the entire cardiac cycle from a single scan, the effective dose 
efficiency is primarily reduced by discarding projection images acquired during 
inspiration.  After correcting for the difference in voxel size and achieved image noise20 
between our study and the prospectively gated study by Badea et al.,7 the dose delivered 
to the animal by our study was made only slightly higher by the exclusion of  data 
acquired during inspiration.  A small improvement in utilization of the acquired data 
could be achieved by averaging volumes reconstructed using all “valid” projections, or if 
projection data occurring during temporally adjacent cardiac or respiratory frames is used 
as well; further investigation is required to evaluate the effect on image blurring and the 
ability to measure cardiac functional parameters.  Depending on the application, the dose 
efficiency could be improved if the mice were ventilated and only cardiac gating was 
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implemented.  Furthermore, the currently used rotation speed may not be the optimal 
gantry-rotation speed to use in terms of dose-optimization.  Faster gantry rotation and 
detector readout would improve the temporal resolution of the scans, as described above, 
and may lead to improved utilization of the x-ray dose as well.  
Although retrospective gating results in the delivery of slightly more dose to the 
animal than is used to reconstruct the images, the dose to the animal is acceptable and 
within the limits set by previously performed studies, as summarized below.  The 28 cGy 
entrance dose reported in the current study will result in a mean absorbed dose of 
approximately 14 cGy in a 2-cm diameter mouse,25 which is similar to that reported in 
previous ungated,10, 26 prospectively gated,6, 7, 11, 27 or retrospectively gated28-30 live-
animal CT studies in mice.  Although this dose is significantly greater than the dose 
reported for clinical diagnostic CT thorax exams in humans (2 to 3.5 cGy),31, 32  it 
remains far lower than the radiation dose associated with conventional therapeutic 
exposures – 5000 cGy total, delivered in dose fractions of up to 1000 cGy.33  The adverse 
effects of irradiating the thorax include pneumonitis, fibrosis, and neoplasia, but over the 
short term, pneumonitis and fibrosis are likely to be the major concerns.  Fortunately, 
mice repair sub-lethal damage quickly, with repair half-times that range from 0.4 to 4 
hours.34, 35  Given the repair kinetics in the mouse lung following therapeutic dose levels, 
34-36  it has been proposed in previous studies that a time interval of 6-8 hours be used 
between repeat exposures of over 100 cGy, in order to allow the majority of tissue repair 
to be completed.37  Thus, we do not anticipate adverse effects in future longitudinal CT-
based studies of cardiac function in mice, given the relatively low entrance exposure 
reported in this study.  
The ability to obtain retrospectively gated cardiac data in this study has depended 
on the availability of an intra-vascular contrast agent, Fenestra VC, which has a long 
biological half-life,38 and provides constant maximum vessel opacification over a period 
of about 2 hours in mice.10  The volume of contrast agent injected in this study 
represented a significant fraction (~25%) of the blood volume of a mouse and may 
potentially have had an impact on mouse cardiac function.  Studies to determine whether 
the volume of contrast agent injected has an effect on cardiac function will need to be 
performed by repeat scanning at with lower administered doses, while maintaining 
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sufficient contrast between the chambers and the myocardium.  Other contrast agents 
with long circulation life-time in vivo are becoming available, and can allow multi-modal 
imaging using the same contrast agent, but may suffer from low iodine loading resulting 
in higher injected volumes.39  Contrast agents with a higher iodine concentration would 
enable the volume of administered contrast agent to be reduced, while maintaining the 
contrast between the blood pool and tissue.  Recently Mukundan et al. described a new 
liposomal-nanoscale iodinated contrast agent with almost double the iodine concentration 
(85 – 100 mg I/ml) compared to that of Fenestra VC, while demonstrating that the 
contrast remains within the vasculature for more than 3 hours, with enhancement after 2 
hours of approximately 600 HU.40  Use of this contrast agent in the retrospectively gated 
cardiac micro-CT studies could enable reduction of the delivered volume of contrast 
agent, or a reduction in x-ray dose, while maintaining SNR  Furthermore, it might also be 
possible to acquire the retrospectively gated cardiac images during a constant infusion of 
clinical, non-ionic, extra-cellular contrast agent, with concentrations of iodine as high as 
350 mg/ml.  Badea et al. showed that by infusing 1 ml of Isovue-370 continuously over 
one hour, contrast enhancement of ~500 HU was achieved after 1 hr.7  A similar 
approach might be applicable here, but would require further evaluation to determine the 
exact protocol required to provide a constant opacification of the vasculature during the 
50-second scan.  Aside from the higher iodine concentration of conventional, rapidly 
clearing contrast agents, the benefit to being able to use such agents in retrospectively 
gated micro-CT would extend the applicability of the technique to larger animals; 
currently the use of intra-vascular contrast agents in rats and rabbits is prohibitively 
expensive.   
The image quality of the retrospectively gate cardiac images is high and amenable 
to automated image analysis.  In this study, automated region growing was used to 
determine the volumes of the chambers, with minimal user intervention near the base of 
the heart.  Ventricular wall mass and thickness, both important parameters used 
clinically, can also be determined from the images but would require further software 
development, given the low contrast between the heart wall and the surrounding tissues, 
such as the chest wall. 
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Future applications in mice will include studies of induced myocardial infarction 
and to monitor therapy, thereby making this an invaluable tool for the study of 
cardiovascular disease in pre-clinical models.  Although others believed that cardiac CT 
in mice might not be possible,41 we have shown that not only is it possible,7 but can be 
performed in free breathing mice in scan times shorter than one minute. 
 
Conclusion 
Combining retrospective cardiac and respiratory gating with the high-speed 
acquisition of x-ray projection images over multiple rotations, using a high-speed 
volumetric micro-CT scanner, has enabled us to obtain 4D images, with 150-#m isotropic 
voxel spacing, of the hearts of free-breathing mice.  Sufficient contrast is provided 
between the myocardium and blood pool through the intravenous injection of an intra-
vascular contrast agent.  This technique promises to become an important tool in the 
study of cardiac disease, since it provides a highly reproducible rapid means to quantify 
cardiac function in acute and longitudinal studies. 
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Appendix B 
Ethics Approval for Animal Subjects 
 
 
 
 
 
 
 
 
 
 
  The University of Western Ontario 
Animal Use Subcommittee / University Council on Animal Care 
Health Sciences Centre, ● London, Ontario ● CANADA – N6A 5C1 
PH: 519-661-2111 ext. 86770 ● FL 519-661-2028 ● www.uwo.ca / animal 
 
           
10.16.09 
 
     *This is the Original Approval for this protocol* 
*A Full Protocol submission will be required in 2013* 
 
Dear Dr.  Drangova: 
 
Your Animal Use Protocol form entitled: 
 
Optimized Micro-CT of the Redent Heart and Coronary Vasculature 
 
Funding Agency  HSFO - Grant # T6293 has been approved by the University Council on Animal Care. 
 
This approval is valid from 10.16.09 to 10.31.13 with a yearly renewal required each year. 
 
The protocol number for this project is 2009-077  
 
1.  This number must be indicated when ordering animals for this project. 
2.  Animals for other projects may not be ordered under this number. 
3.  If no number appears please contact this office when grant approval is received. 
     If the application for funding is not successful and you wish to proceed with the project, request that an internal 
scientific peer review be performed by the Animal Use Subcommittee office. 
4.  Purchases of animals other than through this system must be cleared through the ACVS office.  Health certificates 
will be required. 
 
ANIMALS APPROVED FOR 4 Years   
Species Strain Other Detail Pain Level 
Animal # Total 
 for 4 Years 
Mouse As outlined in Protocol 25g male C 130 
Rat As outlined in Protocol 300g male C 30 
 
REQUIREMENTS/COMMENTS 
Please ensure that individual(s) performing procedures on live animals, as described in this protocol, are familiar with 
the contents of this document. 
 
The holder of this Animal Use Protocol is responsible to ensure that all associated safety 
components (biosafety, radiation safety, general laboratory safety) comply with institutional 
safety standards and have received all necessary approvals.  Please consult directly with your 
institutional safety officers. 
 
 
 
 
 
 
c.c.  J Dunmore-Buyze, M Pickering, W Lagerwerf 
  The University of Western Ontario 
Animal Use Subcommittee / University Council on Animal Care 
Health Sciences Centre, ● London, Ontario ● CANADA – N6A 5C1 
PH: 519-661-2111 ext. 86770 ● FL 519-661-2028 ● www.uwo.ca / animal 
 
 
 
 
 
         
             
         
         
         
                             
11.01.10                                                                   
 *This is the 1st Renewal of this protocol 
*A Full Protocol submission will be required in 2013 
 
 
Dear Dr. Drangova 
 
 
 
Your Animal Use Protocol form entitled: 
 
 
Optimized Micro-CT of the Rodent Heart and Coronary Vasculature 
 
 
has had its yearly renewal approved by the Animal Use Subcommittee.  
 
This approval is valid from  11.01.10  to 11.01.11 
 
The protocol number for this project remains as 2009-077 
 
1.  This number must be indicated when ordering animals for this project. 
2.  Animals for other projects may not be ordered under this number. 
3.  If no number appears please contact this office when grant approval is received. 
     If the application for funding is not successful and you wish to proceed with the project, request that an internal     
     scientific peer review be performed by the Animal Use Subcommittee office. 
4.  Purchases of animals other than through this system must be cleared through the ACVS office.  Health   
     certificates will be required. 
 
 
REQUIREMENTS/COMMENTS 
Please ensure that individual(s) performing procedures on live animals, as described in this protocol, are familiar 
with the contents of this document. 
The holder of this Animal Use Protocol is responsible to ensure that all associated safety 
components (biosafety, radiation safety, general laboratory safety) comply with institutional safety 
standards and have received all necessary approvals.  Please consult directly with your 
institutional safety officers. 
 
      
 
 
 
 
c.c.   J. Dunmore, W. Lagerwerf, M. Pickering        
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Copyright Agreements 
 
 
 
This thesis contains material from previously published manuscripts in Investigative 
Radiology (Chapter 2 and Appendix A), and Contrast Media and Molecular Imaging 
(Chapter 3); the copyright agreements for the three papers are included.  Chapter 4 is 
adapted from a manuscript currently in press with the Journal of Applied Physiology.  
Appropriate reference to the published sources is given in the co-authorship section. 
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